[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_b4c48678-30f3-4f61-9f9b-d1055090e211":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:b4c48678-30f3-4f61-9f9b-d1055090e211,\"}":689},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":661,"relativeEntities":662,"slug":663,"properties":664,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":669,"manageAffiliations":670,"indexDatabases":671,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"b4c48678-30f3-4f61-9f9b-d1055090e211","2023-11-24T07:09:30.132+00:00","2025-11-21T09:57:55.191+00:00",[],"Clinical-and-Applied-Immunology-Reviews",{"issn":665,"title":667},{"VOID":666},"15291049",{"EN":668},"Clinical and Applied Immunology Reviews",[],[],[672],{"id":673,"indexDatabase":674,"url":686,"indexYears":687,"academicFieldIds":26,"indexDatabaseRanking":688},"9e599318-b9ff-4932-9084-9970be40ba4d",{"id":675,"createTime":676,"updateTime":677,"relativeEntities":678,"label":679,"description":681,"key":683,"publicationTags":684,"standard":26},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9","2023-05-22T09:57:18.509+00:00","2025-11-21T10:07:52.274+00:00",[],{"EN":680,"VI":680},"Scopus - Elsevier",{"EN":680,"VI":682},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[685],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F20718","2000-2006","SCOPUS__Q3",{"meta":690,"data":692},{"total":691},"74",[693,734,805,881,916,995,1056,1106,1206,1280],{"id":694,"createTime":695,"updateTime":696,"relativeEntities":697,"slug":698,"properties":699,"entityType":704,"verifyStatus":28,"verifyTime":696,"verifyNote":705,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":706,"fullTextUrl":26,"authors":707,"publicationType":708,"publisherRelationship":709,"citationCount":26,"citationInfo":26,"publishDate":731,"publishYear":732,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":733},"aac49895-2e89-4d9e-a34e-3755f964a64b","2024-01-29T07:13:21.762+00:00","2025-01-28T00:49:54.570+00:00",[],"The-linkage-between-rhinitis-sinusitis-and-asthma",{"title":700,"doi":702},{"EN":701},"The linkage between rhinitis, sinusitis, and asthma",{"VOID":703},"10.1016\u002FS1529-1049(01)00022-8","PUBLICATION","Author title is blank","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1529104901000228",[],"ARTICLE",{"url":706,"publisher":710,"properties":724},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":711,"slug":663,"properties":712,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":715,"manageAffiliations":716,"indexDatabases":717,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":713,"title":714},{"VOID":666},{"EN":668},[],[],[718],{"id":673,"indexDatabase":719,"url":686,"indexYears":687,"academicFieldIds":26,"indexDatabaseRanking":688},{"id":675,"createTime":676,"updateTime":677,"relativeEntities":720,"label":721,"description":722,"key":683,"publicationTags":723,"standard":26},[],{"EN":680,"VI":680},{"EN":680,"VI":682},[685],{"volume":725,"pages":727,"issue":729},{"VOID":726},"1",{"VOID":728},"229-234",{"VOID":730},"3-4","2001-01-01",2001,false,{"id":735,"createTime":736,"updateTime":737,"relativeEntities":738,"slug":739,"properties":740,"entityType":704,"verifyStatus":25,"verifyTime":737,"verifyNote":747,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":748,"fullTextUrl":26,"authors":749,"publicationType":708,"publisherRelationship":783,"citationCount":26,"citationInfo":26,"publishDate":803,"publishYear":804,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":733},"5b743cd5-a07f-447f-a350-9512d6d6bf02","2023-12-11T20:24:35.175+00:00","2025-01-27T23:56:35.002+00:00",[],"Cartilage-degradation-products-as-markers-for-evaluation-of-patients-with-rheumatic-disease",{"references":741,"title":743,"doi":745},{"VOID":742},"Wollheim, 2000, Markers of disease in rheumatoid arthritis, Curr Opin Rheumatol, 12, 200, 10.1097\u002F00002281-200005000-00007\nDeGroot, 2002, Molecular markers for osteoarthritis: the road ahead, Curr Opin Rheumatol, 14, 585, 10.1097\u002F00002281-200209000-00019\nStucki, 1997, Management of rheumatoid arthritis, Curr Opin Rheumatol, 9, 229, 10.1097\u002F00002281-199705000-00009\nScott, 1996, Clinical and laboratory assessments in rheumatoid arthritis and osteoarthritis, Br J Rheumatol, 35, 6, 10.1093\u002Frheumatology\u002F35.suppl_3.6\nOry, 2003, Interpreting radiographic data in rheumatoid arthritis, Ann Rheum Dis, 62, 597, 10.1136\u002Fard.62.7.597\nMøller, 1998, Connective tissue markers of Rheumatoid Arthritis, Scand J Clin Lab Invest, 58, 269, 10.1080\u002F00365519850186445\nChristgau, 2002, Isomerized aggrecan fragments are released during cartilage degradation and can be measured in serum, Osteoarthritis Cartilage, 10, S12\nDeberg, 2003, Cartilage degradation and oxidative damage in osteoarthritic and rheumatoid arthritic patients, Osteoarthritis Cartilage, 11, S15\nGarnero, 2001, Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage, Ann Rheum Dis, 60, 619, 10.1136\u002Fard.60.6.619\nGarnero, 2002, Baseline levels of urinary glucosyl-galactosyl pyridinoline and type II collagen C-telopeptide are associated with progression of joint destruction in patients with early rheumatoid arthritis, Arthritis Rheum, 46, 21, 10.1002\u002F1529-0131(200201)46:1\u003C21::AID-ART10061>3.0.CO;2-Q\nChristgau, 2001, Collagen type II degradation products in urine as an index of cartilage degradation, Bone, 29, 209, 10.1016\u002FS8756-3282(01)00504-X\nØstergård, 2003, Imaging in rheumatoid arthritis–why MRI and ultrasonography can no longer be ignored, Scand J Rheumatol, 32, 63, 10.1080\u002F03009740310000058\nBrandi, 2001, Genetic markers of osteoarticular disorders: facts and hopes, Arthritis Res, 3, 270, 10.1186\u002Far316\nArcher, 2003, The chondrocyte, Int J Biochem Cell Biol, 35, 401, 10.1016\u002FS1357-2725(02)00301-1\nvan der Kraan, 2002, Interaction of chondrocytes, extracellular matrix and growth factors: relevance for articular cartilage tissue engineering, Osteoarthritis Cartilage, 10, 631, 10.1053\u002Fjoca.2002.0806\nMartin, 2002, Aging, articular cartilage chondrocyte senescence and osteoarthritis, Biogerontology, 3, 257, 10.1023\u002FA:1020185404126\nProckop, 1995, Collagens: Molecular biology, diseases and potential for therapy, Annu Rev Biochem, 64, 203, 10.1146\u002Fannurev.bi.64.070195.002155\nNelson, 1998, Evidence for altered synthesis of type II collagen in patients with osteoarthritis, J Clin Invest, 102, 2115, 10.1172\u002FJCI4853\nGarnero, 2002, Uncoupling of type II collagen metabolism predicts progression of joint damage in patients with knee osteoarthritis, Arthritis Rheum, 46, 2613, 10.1002\u002Fart.10576\nEyre, 1991, The collagens of articular cartilage, Semin Arthritis Rheum, 3, 2, 10.1016\u002F0049-0172(91)90035-X\nTakahashi, 1996, Concentrations of pyridinoline and deoxypyridinoline in joint tissues from patients with osteoarthritis or rheumatoid arthritis, Ann Rheum Dis, 55, 324, 10.1136\u002Fard.55.5.324\nFurumitsu, 2000, Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis, J Rheumatol, 27, 64\nChu, 2002, Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog, Osteoarthritis Cartilage, 10, 662, 10.1053\u002Fjoca.2002.0812\nLou, 2000, Aggrecan from start to finish, J Bone Miner Metab, 18, 51, 10.1007\u002Fs007740050011\nHardingham, 1995, The structure of aggrecan and its turnover in cartilage, J Rheumatol, 22, 89\nFawthrop, 1997, Chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in progressive versus non-progressive osteoarthritis, Ann Rheum Dis, 56, 119, 10.1136\u002Fard.56.2.119\nSinger, 1997, Aggrecanase and metalloproteinase-specific aggrecan neo-epitopes are induced in the articular cartilage of mice with collagen II-induced arthritis, Osteoarthritis Cartilage, 5, 407, 10.1016\u002FS1063-4584(97)80045-3\nLark, 1995, Aggrecan degradation in osteoarthritis and rheumatoid arthritis, Acta Orthop Scand Suppl, 266, 92, 10.3109\u002F17453679509157660\nMüller, 1998, COMP (Cartilage Oligomeric Protein) is synthesized in ligament, tendon, meniscus and articular cartilage, Connect Tissue Res, 39, 233, 10.3109\u002F03008209809021499\nDodge, 1998, Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts, Osteoarthritis Cartilage, 6, 435, 10.1053\u002Fjoca.1998.0147\nDi Cesare, 2000, Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts, J Orthop Res, 18, 713, 10.1002\u002Fjor.1100180506\nPetersson, 1998, Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint, Br J Rheumatol, 37, 46, 10.1093\u002Frheumatology\u002F37.1.46\nVilim, 2002, Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis, Osteoarthritis Cartilage, 9, 612, 10.1053\u002Fjoca.2001.0434\nSkoumal, 2003, Serum levels of cartilage oligomeric matrix protein. A predicting factor and a valuable parameter for disease management in rheumatoid arthritis, Scand J Rheumatol, 32, 156, 10.1080\u002F03009740310002498\nDragomir, 2002, Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre-radiographic hip and knee pathology, Osteoarthritis Cartilage, 10, 687, 10.1053\u002Fjoca.2002.0816\nCarlson, 2002, Synovial fluid biomarker levels predict articular cartilage damage following complete medial meniscectomy in the canine knee, J Orthop Res, 20, 92, 10.1016\u002FS0736-0266(01)00066-3\nLiao, 2003, COMP is selectively up-regulated in degenerating acinar cells in chronic pancreatitis and in chronic-pancreatitis-like lesions in pancreatic cancer, Scand J Gastroenterol, 38, 207, 10.1080\u002F00365520310000717\nHarvey, 1998, Chondrex: new marker of joint disease, Clin Chem, 44, 509, 10.1093\u002Fclinchem\u002F44.3.509\nKirkpatrick, 1997, Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages, Exp Cell Res, 237, 46, 10.1006\u002Fexcr.1997.3764\nCawston, 1996, Metalloproteinase inhibitors and the prevention of connective tissue breakdown, Pharmacol Ther, 70, 163, 10.1016\u002F0163-7258(96)00015-0\nPosthumus, 2003, Serum matrix metalloproteinase 3 levels in comparison to C-reactive protein in periods with and without progression of radiological damage in patients with early rheumatoid arthritis, Clin Exp Rheumatol, 21, 465\nBrennan, 1997, Reduction of serum matrix MMP 1 and MMP 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy, Br J Rheumatol, 36, 643, 10.1093\u002Frheumatology\u002F36.6.643\nGreen, 2003, Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis, Rheumatology (Oxford), 42, 83, 10.1093\u002Frheumatology\u002Fkeg037\nIshiguro, 1996, Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis, J Rheumatol, 23, 1599\nManicourt, 1995, Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation, Arthritis Rheum, 38, 1031, 10.1002\u002Fart.1780380803\nAbad, 2002, The role of the resting zone in growth plate chondrogenesis, Endocrinology, 143, 1851, 10.1210\u002Fen.143.5.1851\nVerzijl, 2002, Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis, Arthritis Rheum, 46, 114, 10.1002\u002F1529-0131(200201)46:1\u003C114::AID-ART10025>3.0.CO;2-P\nCloos, 2002, Non-enzymatic covalent modifications of proteins: mechanisms, physiological consequences and clinical applications, Matrix Biol, 21, 39, 10.1016\u002FS0945-053X(01)00188-3\nGarnero, 2003, Biomarkers in osteoarthritis, Curr Opin Rheumatol, 15, 641, 10.1097\u002F00002281-200309000-00020\nChristgau, 2003, Current and future applications of bone turnover markers, Clin Lab, 49, 439\nBettica, 2002, Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study, Arthritis Rheum, 46, 3178, 10.1002\u002Fart.10630\nBlair, 2002, Mechanisms balancing skeletal synthesis and degradation, Biochem J, 364, 329, 10.1042\u002Fbj20020165\nCloos, 2000, Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential, Biochem J, 345, 473, 10.1042\u002F0264-6021:3450473\nChristgau, 2000, Serum crosslaps for monitoring the response in individuals undergoing antiresorptive therapy, Bone, 26, 505, 10.1016\u002FS8756-3282(00)00248-9\nEastell, 2003, Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate, J Bone Miner Res, 18, 1051, 10.1359\u002Fjbmr.2003.18.6.1051\nBruyere, 2003, Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women, Maturitas, 44, 259, 10.1016\u002FS0378-5122(03)00042-2\nDe Ceuninck, 2003, Urinary collagen type II C-telopeptide fragments are sensitive markers of matrix metalloproteinase-dependent cartilage degradation in rat adjuvant-induced arthritis, J Rheumatol, 30, 1561\nLeff, 2003, Molecular changes in human osteoarthritic cartilage after 3 weeks of oral administration of BAY 12-9566, a matrix metalloproteinase inhibitor, J Rheumatol, 30, 544\nShingleton, 2003, In vitro model of human articular cartilage degradation, Methods Mol Biol, 225, 99\nVingsbo-Lundberg, 1998, Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats, Arthritis Rheum, 41, 544, 10.1002\u002F1529-0131(199803)41:3\u003C544::AID-ART21>3.0.CO;2-#\nSeed, 2003, The assessment of inflammation, cartilage matrix, and bone loss in experimental monoarticular arthritis of the rat, Methods Mol Biol, 225, 161\nLindhorst, 2000, Longitudinal characterization of synovial fluid biomarkers in the canine meniscectomy model of osteoarthritis, J Orthop Res, 18, 269, 10.1002\u002Fjor.1100180216\nHarrison, 1998, The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis, J Rheumatol, 25, 2324\nHansen, 1999, A randomized trial of differentiated prednisolone treatment in active rheumatoid arthritis. Clinical benefits and skeletal side effects, Ann Rheum Dis, 58, 713, 10.1136\u002Fard.58.11.713\nJensen, 2001, Connective tissue metabolism in patients with active rheumatoid arthritis during treatment with prednisolone and\u002For DMARD, Ann Rheum Dis, 59, 108\nSharif, 1995, Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint, Br J Rheumatol, 34, 306, 10.1093\u002Frheumatology\u002F34.4.306\nLehmann, 2002, The effects of bisphosphonates on CartiLaps: a new marker for cartilage degradation, Ann Rheum Dis, 61, 530, 10.1136\u002Fard.61.6.530",{"EN":744},"Cartilage degradation products as markers for evaluation of patients with rheumatic disease",{"VOID":746},"10.1016\u002Fj.cair.2004.01.003","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1529104904000042",[750,766],{"id":751,"sortIndex":36,"researcher":26,"roles":752,"affiliations":754,"properties":763},"6f60d961-f952-4c30-bb78-3020427d8159",[753],"AUTHOR",[755],{"id":26,"sortIndex":36,"affiliation":756,"properties":26},{"id":757,"createTime":758,"updateTime":758,"relativeEntities":759,"slug":26,"properties":760,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a60f9472-cc5f-4fa5-b20e-1b1f7cbc9e5a","2023-12-11T20:24:35.196+00:00",[],{"title":761},{"VI":762},"Nordic Bone A\u002FS, Fruebjergvej 3, DK-2100, Copenhagen Ø, Denmark",{"title":764},{"VI":765},"Stephan Christgau",{"id":767,"sortIndex":115,"researcher":26,"roles":768,"affiliations":769,"properties":780},"4e85d34b-6217-4d29-889f-dfb39c21119a",[753],[770],{"id":26,"sortIndex":36,"affiliation":771,"properties":26},{"id":772,"createTime":773,"updateTime":774,"relativeEntities":775,"slug":776,"properties":777,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"f26061eb-2d7c-47c0-985b-f674140bd14d","2024-01-13T20:01:56.446+00:00","2024-12-10T14:20:43.754+00:00",[],"Nordic-Bioscience-Herlev-Denmark",{"title":778},{"VI":779},"Nordic Bioscience, Herlev, Denmark",{"title":781},{"VI":782},"Paul A.C Cloos",{"url":748,"publisher":784,"properties":798},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":785,"slug":663,"properties":786,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":789,"manageAffiliations":790,"indexDatabases":791,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":787,"title":788},{"VOID":666},{"EN":668},[],[],[792],{"id":673,"indexDatabase":793,"url":686,"indexYears":687,"academicFieldIds":26,"indexDatabaseRanking":688},{"id":675,"createTime":676,"updateTime":677,"relativeEntities":794,"label":795,"description":796,"key":683,"publicationTags":797,"standard":26},[],{"EN":680,"VI":680},{"EN":680,"VI":682},[685],{"volume":799,"pages":801},{"VOID":800},"4",{"VOID":802},"277-294","2004-05-01",2004,{"id":806,"createTime":807,"updateTime":808,"relativeEntities":809,"slug":810,"properties":811,"entityType":704,"verifyStatus":25,"verifyTime":808,"verifyNote":747,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":818,"fullTextUrl":26,"authors":819,"publicationType":708,"publisherRelationship":859,"citationCount":26,"citationInfo":26,"publishDate":879,"publishYear":880,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":733},"00d92299-55c0-481d-ad71-6730cfeacf0a","2023-12-14T01:57:35.800+00:00","2025-02-14T01:24:46.759+00:00",[],"Immunosuppressants-Pharmacokinetics-methods-of-monitoring-and-role-of-high-performance-liquid-chromatography-mass-spectrometry",{"references":812,"title":814,"doi":816},{"VOID":813},"Srinivas, 2005, Pharmacokinetic principles of immunosuppressive drugs, Am J Transplant, 5, 207, 10.1111\u002Fj.1600-6143.2005.00748.x\nOffermann, 2004, Immunosuppression for long-term maintenance of renal allograft function, Drugs, 64, 1325, 10.2165\u002F00003495-200464120-00005\nShaw, 1987, Critical issues in cyclosporine monitoring—report of the task-force on cyclosporine monitoring, Clin Chem, 33, 1269, 10.1093\u002Fclinchem\u002F33.7.1269\nWong, 2001, Therapeutic drug monitoring for immunosuppressants, Clin Chim Acta, 313, 241, 10.1016\u002FS0009-8981(01)00678-7\nRezzani, 2004, Cyclosporine A and adverse effects on organs: histochemical studies, Prog Histochem Cytochem, 39, 85, 10.1016\u002Fj.proghi.2004.04.001\nHolt, 2002, Therapeutic drug monitoring of immunosuppressive drugs in kidney transplantation, Curr Opin Nephrol Hypertens, 11, 657, 10.1097\u002F00041552-200211000-00014\nFredericks, 2003, Pharmacogenomics of immunosuppressive drug metabolism, Curr Opin Nephrol Hypertens, 12, 607, 10.1097\u002F00041552-200311000-00006\nThummel, 2004, A genetic test for immunosuppressant dose selection?, Pharmacogenetics, 14, 145, 10.1097\u002F00008571-200403000-00001\nCattaneo, 2004, From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapy, Am J Transplant, 4, 299, 10.1111\u002Fj.1600-6143.2004.00312.x\nDirks, 2004, Pharmacokinetics of immunosuppressants: a perspective on ethnic differences, Int J Clin Pharmacol Ther, 42, 701, 10.5414\u002FCPP42701\nJorgensen, 2003, Calcineurin phosphatase activity and immunosuppression. A review on the role of calcineurin phosphatase activity and the immunosuppressive effect of cyclosporin A and tacrolimus, Scand J Immunol, 57, 93, 10.1046\u002Fj.1365-3083.2003.01221.x\nEllis, 1991, Cyclosporine for plaque-type psoriasis—results of a multidose, double-blind trial, N Engl J Med, 324, 277, 10.1056\u002FNEJM199101313240501\nSpadaro, 1997, Life-table analysis of cyclosporin A treatment in psoriatic arthritis: comparison with other disease-modifying antirheumatic drugs, Clin Exp Rheumatol, 15, 609\nKountouras, 2004, Immunomodulatory benefits of cyclosporine A in inflammatory bowel disease, J Cell Mol Med, 8, 317, 10.1111\u002Fj.1582-4934.2004.tb00321.x\nAkhlaghi, 2002, Distribution of cyclosporin in organ transplant recipients, Clin Pharmacokinet, 41, 615, 10.2165\u002F00003088-200241090-00001\nKaramperis, 2005, Role of metabolites and calcineurin inhibition on C2 monitoring in renal transplant patients, Nephrol Dial Transplant, 20, 618, 10.1093\u002Fndt\u002Fgfh671\nPtachcinski, 1987, Cyclosporine kinetics in healthy-volunteers, J Clin Pharmacol, 27, 243, 10.1002\u002Fj.1552-4604.1987.tb02193.x\nKahan, 2004, Therapeutic drug monitoring of cyclosporine: 20 years of progress, Transplant Proc, 36, 378S, 10.1016\u002Fj.transproceed.2004.01.091\nKeown, 1998, Cyclosporine: the principal immunosuppressant for renal transplantation, Transplant Proc, 30, 1712, 10.1016\u002FS0041-1345(98)00401-1\nBelitsky, 2000, Neoral use in the renal transplant recipient, Transplant Proc, 32, 10S, 10.1016\u002FS0041-1345(00)00860-5\nBelitsky, 2000, Neoral absorption profiling: an evolution in effectiveness, Transplant Proc, 32, 45S, 10.1016\u002FS0041-1345(00)00863-0\nReichenspurner, 2005, Overview of tacrolimus-based immunosuppression after heart or lung transplantation, J Heart Lung Transplant, 24, 119, 10.1016\u002Fj.healun.2004.02.022\nPeters, 1993, Tacrolimus—a review of its pharmacology, and therapeutic potential in hepatic and renal-transplantation, Drugs, 46, 746, 10.2165\u002F00003495-199346040-00009\nChristians, 2002, Mechanisms of clinically relevant drug interactions associated with tacrolimus, Clin Pharmacokinet, 41, 813, 10.2165\u002F00003088-200241110-00003\nPlosker, 2000, Tacrolimus—a further update of its pharmacology and therapeutic use in the management of organ transplantation, Drugs, 59, 323, 10.2165\u002F00003495-200059020-00021\nFirst, 2004, Tacrolimus based immunosuppression, J Nephrol, 17, S25\nFirst, 2004, Improving long-term renal transplant outcomes with tacrolimus: speculation vs evidence, Nephrol Dial Transplant, 19, 17, 10.1093\u002Fndt\u002Fgfh1065\nStaatz, 2004, Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation, Clin Pharmacokinet, 43, 623, 10.2165\u002F00003088-200443100-00001\nWallemacq, 2001, Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients, Clin Pharmacokinet, 40, 283, 10.2165\u002F00003088-200140040-00004\nSaunders, 2001, Rapamycin in transplantation: a review of the evidence, Kidney Int, 59, 3, 10.1046\u002Fj.1523-1755.2001.00460.x\nMahalati, 2001, Clinical pharmacokinetics of sirolimus, Clin Pharmacokinet, 40, 573, 10.2165\u002F00003088-200140080-00002\nZimmerman, 2003, Pharmacokinetic interactions between sirolimus and microemulsion cyclosporine when orally administered jointly and 4 hours apart in healthy volunteers, J Clin Pharmacol, 43, 1168, 10.1177\u002F0091270003257227\nKahan, 2000, Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity, Clin Transpl, 14, 97, 10.1034\u002Fj.1399-0012.2000.140201.x\nKirchner, 2004, Clinical pharmacokinetics of everolimus, Clin Pharmacokinet, 43, 83, 10.2165\u002F00003088-200443020-00002\nKovarik, 2003, Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure, J Heart Lung Transplant, 22, 1117, 10.1016\u002FS1053-2498(02)01221-4\nBullingham, 1998, Clinical pharmacokinetics of mycophenolate mofetil, Clin Pharmacokinet, 34, 429, 10.2165\u002F00003088-199834060-00002\nModer, 2003, Mycophenolate mofetil: new applications for this immunosuppressant, Ann Allergy Asthma Immunol, 90, 15, 10.1016\u002FS1081-1206(10)63607-1\nShaw, 1998, Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function, J Clin Pharmacol, 38, 268, 10.1002\u002Fj.1552-4604.1998.tb04424.x\nPicard, 2005, Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism, Drug Metab Dispos, 33, 139, 10.1124\u002Fdmd.104.001651\nShaw, 1998, Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid, Clin Biochem, 31, 323, 10.1016\u002FS0009-9120(98)00050-2\nPawinski, 2002, Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus, Clin Chem, 48, 1497, 10.1093\u002Fclinchem\u002F48.9.1497\nSalazar, 2001, Sirolimus–tacrolimus combination for combined kidney–pancreas transplantation: effect on renal function, Transplant Proc, 33, 1038, 10.1016\u002FS0041-1345(00)02321-6\nWitzigmann, 2002, Immunosuppression with sirolimus\u002Ftacrolimus combination in pancreas transplantation: 1-year results, Transplant Proc, 34, 3354, 10.1016\u002FS0041-1345(02)03675-8\nRashid, 2002, Medium-term outcome using sirolimus–tacrolimus combination in adult renal transplant recipients, Transplant Proc, 34, 1649, 10.1016\u002FS0041-1345(02)02965-2\nEl-Sabrout, 2002, Improved lipid profile and blood sugar control in pediatric renal transplant recipients using sirolimus–tacrolimus combination, Transplant Proc, 34, 1946, 10.1016\u002FS0041-1345(02)03132-9\nMcAlister, 2000, Sirolimus–tacrolimus combination immunosuppression, Lancet, 355, 376, 10.1016\u002FS0140-6736(99)03882-9\nEl-Sabrout, 2002, Rejection-free protocol using sirolimus–tacrolimus combination for pediatric renal transplant recipients, Transplant Proc, 34, 1942, 10.1016\u002FS0041-1345(02)03130-5\nSadaba, 2004, Clinical relevance of sirolimus drug interactions in transplant patients, Transplant Proc, 36, 3226, 10.1016\u002Fj.transproceed.2004.10.056\nKuypers, 2002, Long-term pharmacokinetic characteristics of the novel combination of tacrolimus and rapamycin in renal transplant recipients, J Am Soc Nephrol, 13, 368A\nBudde, 2005, Influence of everolimus on steady-state pharmacokinetics of cyclosporine in maintenance renal transplant patients, J Clin Pharmacol, 45, 781, 10.1177\u002F0091270005277196\nde Gatta, 2002, Immunosuppressive therapy for paediatric transplant patients—pharmacokinetic considerations, Clin Pharmacokinet, 41, 115, 10.2165\u002F00003088-200241020-00004\nOellerich, 2004, Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients, Clin Biochem, 37, 424, 10.1016\u002Fj.clinbiochem.2004.04.001\nSchubert, 2004, Pharmacokinetics of sirolimus and tacrolimus in pediatric transplant patients, Am J Transplant, 4, 767, 10.1111\u002Fj.1600-6143.2004.00411.x\nShaw, 1999, Current opinions on therapeutic drug monitoring of immunosuppressive drugs, Clin Ther, 21, 1632, 10.1016\u002FS0149-2918(99)80044-7\nBuchberger, 2004, Trace analysis of rapamycin in human blood by micellar electrokinetic chromatography, Anal Bioanal Chem, 380, 68, 10.1007\u002Fs00216-004-2687-x\nMorris, 2002, Cyclosporin monitoring in Australasia: 2002 update of consensus guidelines, Ther Drug Monit, 24, 677, 10.1097\u002F00007691-200212000-00001\nOellerich, 1995, Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel, Ther Drug Monit, 17, 642, 10.1097\u002F00007691-199512000-00017\nKahan, 1990, Consensus document—Hawks-Cay meeting on therapeutic drug-monitoring of cyclosporine, Clin Chem, 36, 1510, 10.1093\u002Fclinchem\u002F36.8.1510\nLevy, 2002, Patient management by Neoral C-2 monitoring: an international consensus statement, Transplantation, 73, S12, 10.1097\u002F00007890-200205151-00003\nSchutz, 1998, Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC, Clin Chem, 44, 2158, 10.1093\u002Fclinchem\u002F44.10.2158\nAndrews, 2002, Cyclosporin: revisions in monitoring guidelines and review of current analytical methods, Ann Clin Biochem, 39, 424, 10.1258\u002F000456302320314430\nMorris, 2005, Immunosuppressant drug monitoring: is the laboratory meeting clinical expectations?, Ann Pharmacother, 39, 119, 10.1345\u002Faph.1E287\nMurthy, 1998, Tacrolimus metabolite cross-reactivity in different tacrolimus assays, Clin Biochem, 31, 613, 10.1016\u002FS0009-9120(98)00086-1\nArmstrong, 2001, New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine, Clin Biochem, 34, 9, 10.1016\u002FS0009-9120(00)00175-2\nWeber, 2002, Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy, Clin Chem, 48, 517, 10.1093\u002Fclinchem\u002F48.3.517\nBeal, 1998, Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay, Ther Drug Monit, 20, 685, 10.1097\u002F00007691-199812000-00019\nAtcheson, 2004, Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia, Ther Drug Monit, 26, 284, 10.1097\u002F00007691-200406000-00011\nSalm, 2000, The quantification of sirolimus by high-performance liquid chromatography–tandem mass spectrometry and microparticle enzyme immunoassay in renal transplant recipients, Clin Ther, 22, B71, 10.1016\u002FS0149-2918(00)89024-4\nSalm, 1999, Analytical performance of microparticle enzyme immunoassay and HPLC–tandem mass spectrometry in the determination of sirolimus in whole blood, Clin Chem, 45, 2278, 10.1093\u002Fclinchem\u002F45.12.2278\nWestley, 2005, CEDIA (R) sirolimus assay compared with HPLC–MS\u002FMS and HPLC–UV in transplant recipient specimens, Ther Drug Monit, 27, 309, 10.1097\u002F01.ftd.0000164394.47520.12\nWu, 2005, Determination of sirolimus in blood by high-performance liquid chromatography with ultraviolet detection—experience and review, J Food Drug Anal, 13, 1\nDasgupta, 1995, Therapeutic monitoring of tacrolimus (FK 506) using liquid chromatography. A review, J Liq Chromatogr, 18, 4029, 10.1080\u002F10826079508013743\nDeters, 2003, Liquid chromatography\u002Fmass spectrometry for therapeutic drug monitoring of immunosuppressants, Anal Chim Acta, 492, 133, 10.1016\u002FS0003-2670(03)00410-0\nNowak, 1995, Mycophenolic-acid binding to human serum-albumin—characterization and relation to pharmacodynamics, Clin Chem, 41, 1011, 10.1093\u002Fclinchem\u002F41.7.1011\nNapoli, 2000, A practical guide to the analysis of sirolimus using high-performance liquid chromatography with ultraviolet detection, Clin Ther, 22, B14, 10.1016\u002FS0149-2918(00)89019-0\nWoolf, 1999, Determination of a macrolide immunosuppressant indolyl-ascomycin derivative in plasma by high performance liquid chromatography with fluorescence detection, J Liq Chromatogr Relat Technol, 22, 981, 10.1081\u002FJLC-100101712\nZambonin, 2004, Determination of the immunosuppressant mycophenolic acid in human serum by solid-phase microextraction coupled to liquid chromatography, J Chromatogr B Analyt Technol Biomed Life Sci, 806, 89, 10.1016\u002Fj.jchromb.2004.03.039\nRenner, 2001, Determination of mycophenolic acid and mycophenolate mofetil by high-performance liquid chromatography using postcolumn derivatization, Anal Chem, 73, 41, 10.1021\u002Fac0006730\nGlish, 2003, The basics of mass spectrometry in the twenty-first century, Nat Rev Drug Discov, 2, 140, 10.1038\u002Fnrd1011\nKeevil, 2002, Rapid liquid chromatography–tandem mass spectrometry method for routine analysis of cyclosporin A over an extended concentration range, Clin Chem, 48, 69, 10.1093\u002Fclinchem\u002F48.1.69\nVolosov, 2001, Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography tandem mass-spectrometry, Clin Biochem, 34, 285, 10.1016\u002FS0009-9120(01)00235-1\nTomer, 2001, Separations combined with mass spectrometry, Chem Rev, 101, 297, 10.1021\u002Fcr990091m\nVogeser, 2005, Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography–tandem mass spectrometry, Clin Chem Lab Med, 43, 400, 10.1515\u002FCCLM.2005.072\nAnnesley, 2003, Ion suppression in mass spectrometry, Clin Chem, 49, 1041, 10.1373\u002F49.7.1041\nSimpson, 1998, A specific method for the measurement of cyclosporin A in human whole blood by liquid chromatography tandem mass spectrometry, Ther Drug Monit, 20, 294, 10.1097\u002F00007691-199806000-00009\nZaater, 2005, Liquid chromatographic–electrospray mass spectrometric determination of cyclosporin A in human plasma, Anal Bioanal Chem, 382, 223, 10.1007\u002Fs00216-005-3196-2\nTaylor, 1998, Microscale high-performance liquid chromatography electrospray tandem mass spectrometry assay for cyclosporin A in blood, J Chromatogr B, 705, 289, 10.1016\u002FS0378-4347(97)00516-1\nHowell, 2004, An innovative blood lead screening program for Indian children, Public Health Rep, 119, 141, 10.1177\u002F003335490411900206\nKeevil, 2002, Simultaneous and rapid analysis of cyclosporin A and creatinine in finger prick blood samples using liquid chromatography tandem mass spectrometry and its application in C2 monitoring, Ther Drug Monit, 24, 757, 10.1097\u002F00007691-200212000-00013\nNankivell, 2004, Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology, Transplantation, 78, 557, 10.1097\u002F01.TP.0000128636.70499.6E\nVollenbroeker, 2005, Determination of cyclosporine and its metabolites in blood via HPLC–MS and correlation to clinically important parameters, Transplant Proc, 37, 1741, 10.1016\u002Fj.transproceed.2005.03.149\nRobb, 2000, Atmospheric pressure photoionisation: an ionization method for liquid chromatography–mass spectrometry, Anal Chem, 72, 3653, 10.1021\u002Fac0001636\nWang, 2005, Comparison of atmospheric pressure chemical ionization, electrospray ionization, and atmospheric pressure photoionization for the determination of cyclosporin A in rat plasma, Anal Chem, 77, 541, 10.1021\u002Fac040144m\nRoberts, 2005, Evaluation of a novel semi-automated HPLC procedure for whole blood cyclosporin A confirms equivalence to adjusted monoclonal values from Abbott TDx, Clin Chem Lab Med, 43, 228, 10.1515\u002FCCLM.2005.039\nBottiger, 1999, Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients, Br J Clin Pharmacol, 48, 445, 10.1046\u002Fj.1365-2125.1999.00007.x\nGonschior, 1995, Simplified high-performance liquid-chromatography mass-spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme-immunoassay, Ther Drug Monit, 17, 504, 10.1097\u002F00007691-199510000-00011\nLensmeyer, 2001, Therapeutic monitoring of tacrolimus concentrations in blood: semi-automated extraction and liquid chromatography–electrospray ionization mass spectrometry, Ther Drug Monit, 23, 239, 10.1097\u002F00007691-200106000-00010\nRamakrishna, 2004, Liquid chromatography–negative ion electrospray tandem mass spectrometry method for the quantification of tacrolimus in human plasma and its bioanalytical applications, J Chromatogr B Analyt Technol Biomed Life Sci, 805, 13, 10.1016\u002Fj.jchromb.2004.02.002\nFeng, 2005, Determination of 13-O-demethyl tacrolimus in human liver microsomal incubates using liquid chromatography–mass spectrometric assay (LC–MS), J Chromatogr B, 821, 31, 10.1016\u002Fj.jchromb.2005.04.010\nBaldelli, 2005, High-performance liquid chromatography with ultraviolet detection for therapeutic drug monitoring of everolimus, J Chromatogr B Analyt Technol Biomed Life Sci, 816, 99, 10.1016\u002Fj.jchromb.2004.11.016\nJones, 2000, Proficiency-testing issues relating to sirolimus, Clin Ther, 22, B122, 10.1016\u002FS0149-2918(00)89028-1\nStreit, 1996, Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC electrospray mass spectrometry, Clin Chem, 42, 1417, 10.1093\u002Fclinchem\u002F42.9.1417\nSalm, 2000, Evaluation of microparticle enzyme immunoassay against HPLC–mass spectrometry for the determination of whole-blood tacrolimus in heart- and lung-transplant recipients, Clin Biochem, 33, 557, 10.1016\u002FS0009-9120(00)00163-6\nTaylor, 1998, Quantitative analysis of sirolimus (Rapamycin) in blood by high-performance liquid chromatography electrospray tandem mass spectrometry, J Chromatogr B, 718, 251, 10.1016\u002FS0378-4347(98)00371-5\nSalm, 2002, Quantification and stability of everolimus (SDZ RAD) in human blood by high-performance liquid chromatography–electrospray tandem mass spectrometry, J Chromatogr B, 772, 283, 10.1016\u002FS1570-0232(02)00107-1\nHallensleben, 2000, Identification of a new metabolite of macrolide immunosuppressant, like rapamycin and SDZ RAD, using high performance liquid chromatography and electrospray tandem mass spectrometry, J Am Soc Mass Spectrom, 11, 516, 10.1016\u002FS1044-0305(00)00123-9\nWallemacq, 2003, High-throughput liquid chromatography–tandem mass spectrometric analysis of sirolimus in whole blood, Clin Chem Lab Med, 41, 921, 10.1515\u002FCCLM.2003.140\nPremaud, 2004, Comparison of liquid chromatography–tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring, Ther Drug Monit, 26, 609, 10.1097\u002F00007691-200412000-00005\nIndjova, 2005, Simultaneous determination of mycophenolic acid and its phenolic glucuronide in human plasma using an isocratic high-performance liquid chromatography procedure, J Chromatogr B Analyt Technol Biomed Life Sci, 817, 327, 10.1016\u002Fj.jchromb.2004.11.020\nWillis, 2000, Quantification of free mycophenolic acid by high-performance liquid chromatography–atmospheric pressure chemical ionisation tandem mass spectrometry, J Chromatogr B, 748, 151, 10.1016\u002FS0378-4347(00)00273-5\nPatel, 2004, Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry, J Chromatogr B Analyt Technol Biomed Life Sci, 813, 287, 10.1016\u002Fj.jchromb.2004.10.004\nAtcheson, 2004, Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection, J Chromatogr B Analyt Technol Biomed Life Sci, 799, 157, 10.1016\u002Fj.jchromb.2003.10.033\nStreit, 2004, Validation of a rapid and sensitive liquid chromatography–tandem mass spectrometry method for free and total mycophenolic acid, Clin Chem, 50, 152, 10.1373\u002Fclinchem.2003.024323\nVogeser, 2001, Potential lack of specificity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum, Ther Drug Monit, 23, 722, 10.1097\u002F00007691-200112000-00021\nPlatzer, 2001, Quantification of mycophenolate mofetil in human skin extracts using high-performance liquid chromatography–electrospray mass spectrometry, J Chromatogr B, 755, 355, 10.1016\u002FS0378-4347(01)00064-0\nLongoria, 1999, Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection, J Thorac Cardiovasc Surg, 117, 714, 10.1016\u002FS0022-5223(99)70291-6\nPoquette, 2005, Effective use of liquid chromatography–mass spectrometry (LC\u002FMS) in the routine clinical laboratory for monitoring sirolimus, tacrolimus, and cyclosporine, Ther Drug Monit, 27, 144, 10.1097\u002F01.ftd.0000148451.35811.74\nKirchner, 1999, LC\u002FESI–MS allows simultaneous and specific quantification of SDZ RAD and cyclosporine, including groups of their metabolites in human blood, Ther Drug Monit, 21, 116, 10.1097\u002F00007691-199902000-00018\nChristians, 2000, Automated, fast and sensitive quantification of drugs in blood by liquid chromatography–mass spectrometry with on-line extraction: immunosuppressants, J Chromatogr B, 748, 41, 10.1016\u002FS0378-4347(00)00380-7\nStreit, 2002, Rapid liquid chromatography–tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood, Clin Chem, 48, 955, 10.1093\u002Fclinchem\u002F48.6.955\nBrignol, 2001, High-throughput semi-automated 96-well liquid\u002Fliquid extraction and liquid chromatography\u002Fmass spectrometric analysis of everolimus (RAD 001) and cyclosporin A (CsA) in whole blood, Rapid Commun Mass Spectrom, 15, 898, 10.1002\u002Frcm.323\nWang, 2005, A fast and simple high-performance liquid chromatography\u002Fmass spectrometry method for simultaneous measurement of whole blood tacrolimus and sirolilmus, Arch Pathol Lab Med, 129, 661, 10.5858\u002F2005-129-0661-AFASHL\nKoal, 2004, Simultaneous determination of four immunosuppressants by means of high speed and robust on-line solid phase extraction–high performance liquid chromatography–tandem mass spectrometry, J Chromatogr B, 805, 215, 10.1016\u002Fj.jchromb.2004.02.040\nCeglarek, 2004, Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry, Clin Chim Acta, 346, 181, 10.1016\u002Fj.cccn.2004.03.017\nHatsis, 2004, Evaluation of a cyano stationary phase for the determination of tacrolimus, sirolimus and cyclosporin A in whole blood by high-performance liquid chromatography–tandem mass spectrometry, J Chromatogr B Analyt Technol Biomed Life Sci, 809, 287, 10.1016\u002FS1570-0232(04)00516-1",{"EN":815},"Immunosuppressants: Pharmacokinetics, methods of monitoring and role of high performance liquid chromatography\u002Fmass spectrometry",{"VOID":817},"10.1016\u002Fj.cair.2005.12.001","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1529104905000747",[820,835,847],{"id":821,"sortIndex":36,"researcher":26,"roles":822,"affiliations":823,"properties":832},"9122eb6d-e4fb-4f05-ad53-3c8d17aea5c3",[753],[824],{"id":26,"sortIndex":36,"affiliation":825,"properties":26},{"id":826,"createTime":827,"updateTime":827,"relativeEntities":828,"slug":26,"properties":829,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"e5313ede-30a1-4ffc-a87b-5044d11c8417","2023-12-14T01:57:35.932+00:00",[],{"title":830},{"VI":831},"Department of Pathology and Laboratory Medicine, Northwestern University Feinberg School of Medicine, Children's Memorial Hospital, Chicago, IL, USA",{"title":833},{"VI":834},"Zheng Yang",{"id":836,"sortIndex":114,"researcher":26,"roles":837,"affiliations":838,"properties":844},"9b08287b-3c11-4478-a4ed-26ffa4d5aab7",[753],[839],{"id":26,"sortIndex":36,"affiliation":840,"properties":26},{"id":826,"createTime":827,"updateTime":827,"relativeEntities":841,"slug":26,"properties":842,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":843},{"VI":831},{"title":845},{"VI":846},"Sihe Wang",{"id":848,"sortIndex":115,"researcher":26,"roles":849,"affiliations":850,"properties":856},"9c7fc109-cbb2-4546-98cc-007721e89ca1",[753],[851],{"id":26,"sortIndex":36,"affiliation":852,"properties":26},{"id":826,"createTime":827,"updateTime":827,"relativeEntities":853,"slug":26,"properties":854,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":855},{"VI":831},{"title":857},{"VI":858},"Yu Peng",{"url":818,"publisher":860,"properties":874},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":861,"slug":663,"properties":862,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":865,"manageAffiliations":866,"indexDatabases":867,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":863,"title":864},{"VOID":666},{"EN":668},[],[],[868],{"id":673,"indexDatabase":869,"url":686,"indexYears":687,"academicFieldIds":26,"indexDatabaseRanking":688},{"id":675,"createTime":676,"updateTime":677,"relativeEntities":870,"label":871,"description":872,"key":683,"publicationTags":873,"standard":26},[],{"EN":680,"VI":680},{"EN":680,"VI":682},[685],{"volume":875,"pages":877},{"VOID":876},"5",{"VOID":878},"405-430","2005-11-01",2005,{"id":882,"createTime":883,"updateTime":884,"relativeEntities":885,"slug":886,"properties":887,"entityType":704,"verifyStatus":28,"verifyTime":884,"verifyNote":705,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":892,"fullTextUrl":26,"authors":893,"publicationType":708,"publisherRelationship":894,"citationCount":26,"citationInfo":26,"publishDate":915,"publishYear":880,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":733},"9daff436-4cdb-4275-838c-0adbfc99a9ef","2024-02-07T17:32:43.529+00:00","2024-12-06T04:23:58.609+00:00",[],"Current-immunotherapy-of-melanoma",{"title":888,"doi":890},{"EN":889},"Current immunotherapy of melanoma",{"VOID":891},"10.1016\u002Fj.cair.2005.01.002","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1529104905000127",[],{"url":892,"publisher":895,"properties":909},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":896,"slug":663,"properties":897,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":900,"manageAffiliations":901,"indexDatabases":902,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":898,"title":899},{"VOID":666},{"EN":668},[],[],[903],{"id":673,"indexDatabase":904,"url":686,"indexYears":687,"academicFieldIds":26,"indexDatabaseRanking":688},{"id":675,"createTime":676,"updateTime":677,"relativeEntities":905,"label":906,"description":907,"key":683,"publicationTags":908,"standard":26},[],{"EN":680,"VI":680},{"EN":680,"VI":682},[685],{"volume":910,"pages":911,"issue":913},{"VOID":876},{"VOID":912},"111-132",{"VOID":914},"2","2005-03-01",{"id":917,"createTime":918,"updateTime":918,"relativeEntities":919,"slug":26,"properties":920,"entityType":704,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":927,"fullTextUrl":26,"authors":928,"publicationType":708,"publisherRelationship":974,"citationCount":26,"citationInfo":26,"publishDate":993,"publishYear":994,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":733},"1a66a2db-536e-4f8e-b8b1-b9ec9694d100","2023-12-13T05:56:25.671+00:00",[],{"references":921,"title":923,"doi":925},{"VOID":922},"Cramer, 2000, The epidemiology of recurrent pregnancy loss, Semin Reprod Med, 18, 331, 10.1055\u002Fs-2000-13722\nNybo Andersen, 2000, Maternal age and fetal loss, BMJ, 320, 1708, 10.1136\u002Fbmj.320.7251.1708\nCoulam, 1996, Immunotherapy for recurrent pregnancy loss, Am J Reprod Immunol, 35, 352, 10.1111\u002Fj.1600-0897.1996.tb00493.x\nGeva, 1995, Autoimmune disorders, Hum Reprod, 10, 2560, 10.1093\u002Foxfordjournals.humrep.a135745\nTempleton, 1996, Factors that affect outcome of in vitro fertilisation treatment, Lancet, 348, 1402, 10.1016\u002FS0140-6736(96)05291-9\nGleicher, 1985, IgM gammopathy and the lupus anticoagulant syndrome in habitual aborters, JAMA, 253, 3278, 10.1001\u002Fjama.1985.03350460078025\nXu, 1990, Antinuclear antibodies in sera of patients with recurrent pregnancy wastage, Am J Obstet Gynecol, 163, 1493, 10.1016\u002F0002-9378(90)90612-B\nStagnaro-Green, 1990, Detection of at-risk pregnancy by means of highly sensitive assays for thyroid antibodies, JAMA, 264, 1422, 10.1001\u002Fjama.1990.03450110068029\nMecacci, 2000, Thyroid autoimmunity and its association with non-organ-specific antibodies and subclinical alterations of thyroid function in women with a history of pregnancy loss or preeclampsia, J Reprod Immunol, 46, 39, 10.1016\u002FS0165-0378(99)00055-8\nMaier, 1989, Subclinical autoimmunity in recurrent aborters, Fertil Steril, 51, 280, 10.1016\u002FS0015-0282(16)60491-0\nSilver, 1994, Recurrent miscarriage, Clin Obstet Gynecol, 37, 745, 10.1097\u002F00003081-199409000-00025\nCoulam, 1995, Systemic CD56+ cells can predict pregnancy outcome, Am J Reprod Immunol, 33, 40, 10.1111\u002Fj.1600-0897.1995.tb01136.x\nHill, 1995, T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion, JAMA, 273, 1933, 10.1001\u002Fjama.1995.03520480053039\nLachapelle, 1996, Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion, J Immunol, 156, 4027, 10.4049\u002Fjimmunol.156.10.4027\nHaddad, 1997, Early embryo loss is associated with the prior expression of macrophage activation markers in the decidua, J Immunol, 158, 4886, 10.4049\u002Fjimmunol.158.10.4886\nRand, 1997, Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism, N Engl J Med, 337, 154, 10.1056\u002FNEJM199707173370303\nBlank, 1991, Induction af anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies, Proc Natl Acad Sci USA, 88, 3069, 10.1073\u002Fpnas.88.8.3069\nGeva, 1999, The possible role of antiovary antibodies in repeated in vitro fertilization failures, Am J Reprod Immunol, 42, 292, 10.1111\u002Fj.1600-0897.1999.tb00104.x\nRosove, 1990, Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies, Obstet Gynecol, 75, 630\nKutteh, 1996, Antiphospholipid antibody-associated recurrent pregnancy loss, Am J Obstet Gynecol, 174, 1584, 10.1016\u002FS0002-9378(96)70610-5\nLecuru, 1996, Anticoagulant therapy during pregnancy, Acta Obstet Gynecol Scand, 75, 217, 10.3109\u002F00016349609047090\nCenters for Disease Control, 1998, Pregnancy-related death associated with heparin and aspirin treatment for infertility, 1996, Morb Mortal Wkly Rep, 47, 368\nLaskin, 1997, Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss, N Engl J Med, 337, 148, 10.1056\u002FNEJM199707173370302\nDaya, 1994, The effectiveness of allogeneic leukocyte immunization in unexplained primary recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group, Am J Reprod Immunol, 32, 294, 10.1111\u002Fj.1600-0897.1994.tb01129.x\nFraser, 1993, Immunization as therapy for recurrent spontaneous abortion, Obstet Gynecol, 82, 854\nGerman RSA\u002FIVIG Group, 1994, Intravenous immunoglobulin in the prevention of recurrent miscarriage, Br J Obstet Gynecol, 101, 1072, 10.1111\u002Fj.1471-0528.1994.tb13584.x\nChristiansen, 1995, Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin, Hum Reprod, 10, 2690, 10.1093\u002Foxfordjournals.humrep.a135769\nPerino, 1997, Short-term therapy for recurrent abortion using intravenous immunoglobulins, Hum Reprod, 12, 2388, 10.1093\u002Fhumrep\u002F12.11.2388\nStephenson, 1998, Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin, Am J Reprod Immunol, 39, 82, 10.1111\u002Fj.1600-0897.1998.tb00339.x\nJablonowska, 1999, Prevention of recurrent spontaneous abortion by intravenous immunoglobulin, Hum Reprod, 14, 838, 10.1093\u002Fhumrep\u002F14.3.838\nBalasch, 1996, Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer, Fertil Steril, 65, 655, 10.1016\u002FS0015-0282(16)58170-9\nStephenson, 2000, Treatment of repeated unexplained in vitro fertilization failure with intravenous immunoglobulin, Fertil Steril, 74, 1108, 10.1016\u002FS0015-0282(00)01622-8\nCoulam, 1995, Intravenous immunoglobulin for treatment of recurrent pregnancy loss, Am J Reprod Immunol, 34, 333, 10.1111\u002Fj.1600-0897.1995.tb00960.x\nKiprov, 1996, The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities, Am J Reprod Immunol, 36, 228, 10.1111\u002Fj.1600-0897.1996.tb00168.x\nStricker, 2000, Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin, Fertil Steril, 73, 536, 10.1016\u002FS0015-0282(99)00572-5\nCoulam, 1994, Intravenous immunoglobulin for in-vitro fertilization failure, Hum Reprod, 9, 2265, 10.1093\u002Foxfordjournals.humrep.a138435\nSher, 1998, A rational basis for the use of combined heparin\u002Faspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies, Am J Reprod Immunol, 39, 391, 10.1111\u002Fj.1600-0897.1998.tb00375.x\nSher, 1998, The use of combined heparin\u002Faspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies, Am J Reprod Immunol, 39, 223, 10.1111\u002Fj.1600-0897.1998.tb00357.x\nScher, 2000, Clinical experience with IVIg Rx in patients with prior failed IVF pregnancies, Am J Reprod Immunol, 44, 121, 10.1111\u002Fj.8755-8920.2000.440208.x\nLiblau, 1992, Selective IgA deficiency and autoimmunity, Int Arch Allergy Immunol, 99, 16, 10.1159\u002F000236330\nMathur, 2000, Autoimmunity in endometriosis, Am J Reprod Immunol, 44, 89, 10.1111\u002Fj.8755-8920.2000.440204.x\nDau, 1994, Immune modulation during treatment of systemic sclerosis with plasmapheresis and immunosuppressive drugs, Clin Immunol Immunopathol, 70, 159, 10.1006\u002Fclin.1994.1024\nReid, 1998, Striking a balance in maternal immune response to infection, Lancet, 351, 1670, 10.1016\u002FS0140-6736(98)22023-X\nPiccinni, 1998, Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions, Nat Med, 4, 1020, 10.1038\u002F2006\nSacks, 1999, An innate view of human pregnancy, Immunol Today, 20, 114, 10.1016\u002FS0167-5699(98)01393-0\nCoulam, 1994, Immunotherapy for recurrent abortion, Am J Reprod Immunol, 32, 257, 10.1111\u002Fj.1600-0897.1994.tb01122.x\nRuiz, 1996, Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion, Am J Reprod Immunol, 35, 370, 10.1111\u002Fj.1600-0897.1996.tb00496.x\nKwak, 1996, Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions, Am J Reprod Immunol, 35, 363, 10.1111\u002Fj.1600-0897.1996.tb00495.x\nRigal, 1994, Effects of intravenous immunoglobulins (IVIG) on peripheral blood B, NK, and T cell subpopulations in women with recurrent spontaneous abortions, Clin Immunol Immunopathol, 71, 309, 10.1006\u002Fclin.1994.1091\nAukrust, 1997, Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo, Clin Exp Immunol, 107, 50, 10.1046\u002Fj.1365-2249.1997.d01-904.x\nPrasad, 1998, Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes, J Immunol, 161, 3781, 10.4049\u002Fjimmunol.161.7.3781\nZhang, 2000, Reemergence of sucrose nephropathy, South Med J, 93, 901, 10.1097\u002F00007611-200093090-00013\nCarp, 1997, Allogenic leukocyte immunization after five or more miscarriages. Recurrent Miscarriage Immunotherapy Trialists Group, Hum Reprod, 12, 250, 10.1093\u002Fhumrep\u002F12.2.250\nClark, 1997, The use of allogeneic leukocytes or i.v. IgG for the treatment of patients with recurrent spontaneous abortions, Transfus Med Rev, 11, 85, 10.1053\u002Ftm.1997.0110085\nConcato, 2000, Randomized, controlled trials, observational studies, and the hierarchy of research designs, N Engl J Med, 342, 1887, 10.1056\u002FNEJM200006223422507\nBenson, 2000, A comparison of observational studies and randomized, controlled trials, N Engl J Med, 342, 1878, 10.1056\u002FNEJM200006223422506\nIoannidis, 2001, Comparison of evidence of treatment effects in randomized and nonrandomized studies, JAMA, 286, 821, 10.1001\u002Fjama.286.7.821\nSher, 2001, “In silico experiments”–yes, but the great western cowboy “random chance” is still alive, Fertil Steril, 76, 636, 10.1016\u002FS0015-0282(01)01950-1",{"EN":924},"Intravenous immunoglobulin (IVIG) therapy for immunologic abortion",{"VOID":926},"10.1016\u002Fs1529-1049(02)00046-6","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1529104902000466",[929,944,959],{"id":930,"sortIndex":36,"researcher":26,"roles":931,"affiliations":932,"properties":941},"170e1176-f9a6-4f2d-a211-07e914644036",[753],[933],{"id":26,"sortIndex":36,"affiliation":934,"properties":26},{"id":935,"createTime":936,"updateTime":936,"relativeEntities":937,"slug":26,"properties":938,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"f97b9cdc-a1b3-4237-8bd6-52f7f237d8e9","2023-12-13T05:56:25.684+00:00",[],{"title":939},{"VI":940},"California Pacific Medical Center, 450 Sutter Street, Suite 1504, San Francisco, CA 94108 USA",{"title":942},{"VI":943},"Raphael B Stricker",{"id":945,"sortIndex":115,"researcher":26,"roles":946,"affiliations":947,"properties":956},"51570a6b-96f6-47f1-9b31-40f34f08b14c",[753],[948],{"id":26,"sortIndex":36,"affiliation":949,"properties":26},{"id":950,"createTime":951,"updateTime":951,"relativeEntities":952,"slug":26,"properties":953,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"638a5881-e374-406f-8c74-3bff0c0ebe8f","2023-12-13T05:56:25.697+00:00",[],{"title":954},{"VI":955},"Astarte Medical Group, 450 Sutter Street, Suite 2215, San Francisco, CA 94108 USA",{"title":957},{"VI":958},"Alex Steinleitner",{"id":960,"sortIndex":114,"researcher":26,"roles":961,"affiliations":962,"properties":971},"2a605cb7-98c1-436d-a846-5ffa1b9aa7ca",[753],[963],{"id":26,"sortIndex":36,"affiliation":964,"properties":26},{"id":965,"createTime":966,"updateTime":966,"relativeEntities":967,"slug":26,"properties":968,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"4d436172-a843-4d77-8c2a-e2162ecd46be","2023-12-13T05:56:25.714+00:00",[],{"title":969},{"VI":970},"Immunodiagnostic Laboratories, 10930 Bigge Street, San Leandro, CA 94577 USA",{"title":972},{"VI":973},"Edward E Winger",{"url":927,"publisher":975,"properties":989},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":976,"slug":663,"properties":977,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":980,"manageAffiliations":981,"indexDatabases":982,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":978,"title":979},{"VOID":666},{"EN":668},[],[],[983],{"id":673,"indexDatabase":984,"url":686,"indexYears":687,"academicFieldIds":26,"indexDatabaseRanking":688},{"id":675,"createTime":676,"updateTime":677,"relativeEntities":985,"label":986,"description":987,"key":683,"publicationTags":988,"standard":26},[],{"EN":680,"VI":680},{"EN":680,"VI":682},[685],{"volume":990,"pages":991},{"VOID":914},{"VOID":992},"187-199","2002-06-01",2002,{"id":996,"createTime":997,"updateTime":998,"relativeEntities":999,"slug":1000,"properties":1001,"entityType":704,"verifyStatus":25,"verifyTime":998,"verifyNote":747,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1008,"fullTextUrl":26,"authors":1009,"publicationType":708,"publisherRelationship":1037,"citationCount":26,"citationInfo":26,"publishDate":731,"publishYear":732,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":733},"61747a57-0eb3-4885-a684-d3518eb89a50","2023-12-24T17:36:23.380+00:00","2025-02-02T11:09:01.002+00:00",[],"The-irreversible-component-of-airway-obstruction-in-asthma",{"references":1002,"title":1004,"doi":1006},{"VOID":1003},"Brown, 1984, Asthma and irreversible airflow obstruction, Thorax, 39, 131, 10.1136\u002Fthx.39.2.131\nMelillo E, Lo Schiavo M, De Felice A. et al. How reversible is airway obstruction in asthma? In: May KL, Hofman T, editors. Management of Asthma. Proceedings of Annual Meeting of Interasma. Poznan, Poland: 1995. p. 39–43.\nBackman, 1997, Airflow obstruction in patients with long-term asthma consistent with irreversible asthma, Chest, 112, 1234, 10.1378\u002Fchest.112.5.1234\nCarter, 1997, Asthma, J Invest Allergol Clin. Immunol, 7, 566\nBousquet, 1995, Airway remodelling in asthma. No doubt or more?, Int Arch Allergy Immunol, 107, 211, 10.1159\u002F000236980\nAmett, 1999, Mast cells and eosinophils, ACI International, 11, 22\nMelillo, 1994, Dose-response curve to inhaled salbutamot in patients with bronchial asthma, Am J Resp Crit Care Med, 149, 205\nKnox, 1994, Airway remodelling in asthma. Role of airway smooth muscle, Clin Sci, 86, 647, 10.1042\u002Fcs0860647\nClive, 1995, Is asthma a fibrotic disease?, Chest, 107, 111, 10.1378\u002Fchest.107.3_Supplement.111S\nBousquet J, Vignola M, Chanez P, et al. What is the clinical relevance of inflammation and the optimal approach? International Respiratory Forum. Colwood House Med Publ, UK, 1997;3:36–42.\n1997\nRedington, 1997, Airway wall remodelling in asthma, Thorax, 52, 310, 10.1136\u002Fthx.52.4.310\nHoggs, 1990, Pathology of asthma, 1\nRoche, 1989, Subepithelial fibrosis in the bronchi of asthmatics, Lancet, 1, 520, 10.1016\u002FS0140-6736(89)90067-6\nMinshall, 1997, Eosinophil-associated TGF-bl mRNA expression and airways fibrosis in bronchial asthma, Am J Respir Cell Mol Biol, 17, 326, 10.1165\u002Fajrcmb.17.3.2733\nSobonya, 1984, Concise clinical study. Quantitative structural alterations in long-standing allergic asthma, Am Rev Resp Dis, 130, 289, 10.1164\u002Farrd.1984.130.2.289\nGabrielli, 1994, Myofibroblast and elastic and collagen hyperplasia in bronchial mucosa. A possible basis for the progressive irreversibility of airway obstruction in chronic asthma, Pathologica, 86, 157\nJeffery, 1992, Effects of treatment on airway inflammation and thickening membrane reticular collagen in asthma, Am Rev Resp Dis, 145, 918\nLundgren, 1988, Morphological studies of bronchial biopsies from asthmatics before and after ten years of treatment of inhaled steroids, Eur Resp J, 1, 883, 10.1183\u002F09031936.93.01100883\nTrigg, 1994, Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma, Am J Resp Crit Care Med, 150, 17, 10.1164\u002Fajrccm.150.1.8025745\nOlivieri, 1997, Effect of short-term treatment with low-dose inhaled fluticasone dipropionate on airway inflammation and remodelling in mild asthma, Am J Resp Crit Care Med, 155, 1864, 10.1164\u002Fajrccm.155.6.9196087\nSaetta, 1995, Airway wall remodelling after cessation of exposure to isocyonate in sensitized asthmatic subjects, Am J Resp Crit Care Med, 151, 489, 10.1164\u002Fajrccm.151.2.7842211\nHaahtela, 1994, Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma, New Eng. J. Med., 331, 737, 10.1056\u002FNEJM199409153311103\nAgertoft, 1994, Effects of long term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children, Respir Med, 88, 373, 10.1016\u002F0954-6111(94)90044-2",{"EN":1005},"The irreversible component of airway obstruction in asthma",{"VOID":1007},"10.1016\u002Fs1529-1049(01)00019-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1529104901000198",[1010,1025],{"id":1011,"sortIndex":115,"researcher":26,"roles":1012,"affiliations":1013,"properties":1022},"879e88a9-5381-4311-bb22-9bacab794e3b",[753],[1014],{"id":26,"sortIndex":36,"affiliation":1015,"properties":26},{"id":1016,"createTime":1017,"updateTime":1017,"relativeEntities":1018,"slug":26,"properties":1019,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"50acb0e0-4fe4-491d-b88a-3440582ab074","2023-12-24T17:36:23.459+00:00",[],{"title":1020},{"VI":1021},"Foundation “S. Maugeri” – Care and Research Institute, Division of Pneumology and Asthma Center, Clinic of Rehabilitation, Telese Terme, Italy",{"title":1023},{"VI":1024},"E. Melillo",{"id":1026,"sortIndex":36,"researcher":26,"roles":1027,"affiliations":1028,"properties":1034},"3f860b20-98d5-41d1-b408-09f8544245ca",[753],[1029],{"id":26,"sortIndex":36,"affiliation":1030,"properties":26},{"id":1016,"createTime":1017,"updateTime":1017,"relativeEntities":1031,"slug":26,"properties":1032,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1033},{"VI":1021},{"title":1035},{"VI":1036},"G. Melillo",{"url":1008,"publisher":1038,"properties":1052},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":1039,"slug":663,"properties":1040,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1043,"manageAffiliations":1044,"indexDatabases":1045,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1041,"title":1042},{"VOID":666},{"EN":668},[],[],[1046],{"id":673,"indexDatabase":1047,"url":686,"indexYears":687,"academicFieldIds":26,"indexDatabaseRanking":688},{"id":675,"createTime":676,"updateTime":677,"relativeEntities":1048,"label":1049,"description":1050,"key":683,"publicationTags":1051,"standard":26},[],{"EN":680,"VI":680},{"EN":680,"VI":682},[685],{"volume":1053,"pages":1054},{"VOID":726},{"VOID":1055},"235-242",{"id":1057,"createTime":1058,"updateTime":1059,"relativeEntities":1060,"slug":1061,"properties":1062,"entityType":704,"verifyStatus":25,"verifyTime":1059,"verifyNote":747,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1069,"fullTextUrl":26,"authors":1070,"publicationType":708,"publisherRelationship":1086,"citationCount":26,"citationInfo":26,"publishDate":1105,"publishYear":880,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":733},"24adfcb3-fa9f-4aec-8549-e4c5f0b99224","2024-01-27T17:06:07.772+00:00","2024-12-09T01:19:43.894+00:00",[],"Stressor-induced-alteration-of-health-across-the-life-span-There-s-more-to-it-than-immunology",{"references":1063,"title":1065,"doi":1067},{"VOID":1064},"Rabin, 1999\nCohen, 1993, Negative life events, perceived stress, negative affect, and susceptibility to the common cold, J Pers Soc Psychol, 64, 131, 10.1037\u002F0022-3514.64.1.131\nHerbert, 1993, Stress and immunity in humans: a meta-analytic review, Psychosom Med, 55, 364, 10.1097\u002F00006842-199307000-00004\nKiecolt-Glaser, 1993, Negative behavior during marital conflict is associated with immunological down-regulation, Psychosom Med, 55, 395, 10.1097\u002F00006842-199309000-00001\nBenschop, 1996, Catecholamine-induced leukocytosis: early observations, current research, and future directions, Brain Behav Immun, 10, 77, 10.1006\u002Fbrbi.1996.0009\nBenschop, 1993, Beta-2 adrenergic stimulation causes detachment of natural killer cells from cultured endothelium, Eur J Immunol, 23, 3242, 10.1002\u002Feji.1830231230\nBenschop, 1994, Beta adrenergic blockade: effects of beta-adrenergic blockade on immunologic and cardiovascular changes induced by mental stress, Circulation, 89, 762, 10.1161\u002F01.CIR.89.2.762\nDhabhar, 2002, Stress-induced augmentation of immune function-the role of stress hormones, leukocyte trafficking, and cytokines, Brain Behav Immun, 16, 785, 10.1016\u002FS0889-1591(02)00036-3\nSegerstrom, 2004, Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry, Psychol Bull, 130, 601, 10.1037\u002F0033-2909.130.4.601\nManuck, 1991, Individual differences in cellular immune response to stress, Psychol Sci, 2, 1, 10.1111\u002Fj.1467-9280.1991.tb00110.x\nNaliboff, 1991, Immunological changes in young and old adults during brief laboratory stress, Psychosom Med, 53, 121, 10.1097\u002F00006842-199103000-00002\nBachen, 1992, Lymphocyte subset and cellular immune responses to a brief experimental stressor, Psychosom Med, 54, 673, 10.1097\u002F00006842-199211000-00007\nSchleifer, 1983, Suppression of lymphocyte stimulation following bereavement, J Am Med Assoc, 250, 374, 10.1001\u002Fjama.1983.03340030034024\nKiecolt-Glaser, 1986, Modulation of cellular immunity in medical students, J Behav Med, 9, 5, 10.1007\u002FBF00844640\nTaylor, 1989, Immunological analysis of US space shuttle crew members, Aviat Space Med, 57, 213\nBartrop, 1977, Depressed lymphocyte function after bereavement, Lancet, 1, 834, 10.1016\u002FS0140-6736(77)92780-5\nKiecolt-Glaser, 1987, Marital quality, marital disruption, and immune function, Psychosom Med, 49, 13, 10.1097\u002F00006842-198701000-00002\nKiecolt-Glaser, 1988, Marital discord and immunity in males, Psychosom Med, 50, 213, 10.1097\u002F00006842-198805000-00001\nKiecolt-Glaser, 1991, Spousal caregivers of dementia victims: longitudinal changes in immunity and health, Psychosom Med, 53, 345, 10.1097\u002F00006842-199107000-00001\nGlaser, 1990, Psychological stress-induced modulation of interleukin 2 receptor gene expression and interleukin 2 production in peripheral blood leukocytes, Arch Gen Psychiatry, 47, 707, 10.1001\u002Farchpsyc.1990.01810200015002\nFleshner, 1996, RU486 blocks differentially suppressive effects of stress on in vivo anti-KLH immunoglobulin response, Am J Physiol, 40, R1344\nGlaser, 1992, Stress-induced modulation of the immune response to recombinant hepatitis B vaccine, Psychosom Med, 54, 22, 10.1097\u002F00006842-199201000-00005\nKiecolt-Glaser, 1996, Chronic stress alters the immune response to influenza virus vaccine in older adults, Proc Natl Acad Sci U S A, 93, 3043, 10.1073\u002Fpnas.93.7.3043\nCoe, 1988, Effect of maternal separation on the complement system and antibody responses in infant primates, Int J Neurosci, 40, 289, 10.3109\u002F00207458808990717\nCunnick, 1991, Alterations in specific antibody production due to rank and social instability, Brain Behav Immun, 5, 357, 10.1016\u002F0889-1591(91)90031-5\nPetry, 1991, Relationship of stress, distress, and the immunologic response to a recombinant hepatitis vaccine, J Fam Pract, 32, 481\nWood, 1993, Enhancement of antigen-specific humoral and cell-mediated immunity by electric footshock stress in rats, Brain Behav Immun, 7, 121, 10.1006\u002Fbrbi.1993.1014\nVedhara, 1996, The assessment of the emotional and immunological consequences of examination stress, J Behav Med, 19, 467, 10.1007\u002FBF01857679\nGmunder, 1994, Cellular immunity in cosmonauts during long duration spaceflight on board the orbital MIR station, Aviat Space Environ Med, 65, 419\nTingate, 1997, Antarctic isolation: immune and viral studies, Immunol Cell Biol, 75, 275, 10.1038\u002Ficb.1997.42\nSmith, 2004, Influences of distress and alcohol consumption on the development of a delayed-type hypersensitivity skin test response, Psychosom Med, 66, 614, 10.1097\u002F01.psy.0000130962.28801.af\nMiller, 1991, Adrenal steroid receptor activation in vivo and immune function, Am J Physiol, 261, E126\nDaynes, 1989, Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4, Eur J Immunol, 19, 2319, 10.1002\u002Feji.1830191221\nElenkov, 2004, Glucocorticoids and the Th1\u002FTh2 balance, Ann N Y Acad Sci, 1024, 138, 10.1196\u002Fannals.1321.010\nDeinzer, 1997, Adrenocortical responses to repeated parachute jumping and subsequent h-CRH challenge in inexperienced healthy subjects, Physiol Behav, 61, 507, 10.1016\u002FS0031-9384(96)00465-9\nBachen, 1995, Adrenergic blockade ameliorates cellular immune responses to mental stress in humans, Psychosom Med, 57, 366, 10.1097\u002F00006842-199507000-00008\nMaisel, 1991, Propranolol treatment affects parameters of human immunity, Immunopharmacology, 22, 157, 10.1016\u002F0162-3109(91)90040-6\nScheier, 1987, Dispositional optimism and physical well-being: the influence of generalized outcome expectancies on health, J Pers, 55, 169, 10.1111\u002Fj.1467-6494.1987.tb00434.x\nMiller, 1999, Personality and tonic cardiovascular, neuroendocrine, and immune parameters, Brain Behav Immun, 13, 109, 10.1006\u002Fbrbi.1998.0545\nSegerstrom, 1998, Optimism is associated with mood, coping, and immune change in response to stress, J Pers Soc Psychol, 74, 1646, 10.1037\u002F0022-3514.74.6.1646\nCohen, 1997, Social ties and susceptibility to the common cold, JAMA, 277, 1940, 10.1001\u002Fjama.1997.03540480040036\nBroadbent, 1984, Some further studies on the prediction of experimental colds in volunteers by psychological factors, J Psychosom Res, 28, 511, 10.1016\u002F0022-3999(84)90085-0\nCohen, 1997, Social ties and susceptibility to the common cold, JAMA, 277, 1940, 10.1001\u002Fjama.1997.03540480040036\nCohen, 1997, Chronic social stress, social status, and susceptibility to upper respiratory infections in nonhuman primates, Psychosom Med, 59, 213, 10.1097\u002F00006842-199705000-00001\nCohen, 2003, Emotional style and susceptibility to the common cold, Psychosom Med, 65, 652, 10.1097\u002F01.PSY.0000077508.57784.DA\nFriedman, 2000, Long-term relations of personality and health: dynamisms, mechanisms, tropisms, J Pers, 68, 1089, 10.1111\u002F1467-6494.00127\nKubzansky, 2001, Is the glass half empty or half full? A prospective study of optimism and coronary heart disease in the normative aging study, Psychosom Med, 63, 910, 10.1097\u002F00006842-200111000-00009\nScheier, 1999, Optimism and rehospitalization after coronary artery bypass graft surgery, Arch Intern Med, 159, 829, 10.1001\u002Farchinte.159.8.829\nSesso, 1998, Depression and the risk of coronary heart disease in the normative aging study, Am J Cardiol, 82, 851, 10.1016\u002FS0002-9149(98)00491-3\nOstir, 2001, The association between emotional well-being and the incidence of stroke in older adults, Psychosom Med, 63, 210, 10.1097\u002F00006842-200103000-00003\nChang, 2002, Anger in young men and subsequent premature cardiovascular disease: the precursors study, Arch Intern Med, 162, 901, 10.1001\u002Farchinte.162.8.901\nStrike, 2004, Psychosocial factors in the development of coronary artery disease, Prog Cardiovasc Dis, 46, 337, 10.1016\u002Fj.pcad.2003.09.001\nGlass, 1993, Impact of social support on outcome in first stroke, Stroke, 24, 64, 10.1161\u002F01.STR.24.1.64\nReifman, 1995, Social relationships, recovery from illness, and survival: a literature review, Ann Behav Med, 17, 124, 10.1007\u002FBF02895061\nColantonio, 1993, Psychosocial predictors of stroke outcomes in an elderly population, J Gerontol: Social Sci, 48, S261, 10.1093\u002Fgeronj\u002F48.5.S261\nVogt, 1994, Mental health status as a predictor of morbidity and mortality: a 15 year follow-up of members of a health maintenance organization, Am J Public Health, 84, 227, 10.2105\u002FAJPH.84.2.227\nLevin, 1998, Religion, health, and psychological well-being in older adults: findings from three national surveys, J Aging Health, 10, 504, 10.1177\u002F089826439801000406\nMatthews, 1994, vol. 1\nSansone, 1996, Borderline personality disorder and health care utilization in a primary care setting, South Med J, 89, 1162, 10.1097\u002F00007611-199612000-00006\nKoenig, 1998, Use of hospital services, religious attendance, and religious affiliation, South Med J, 91, 925, 10.1097\u002F00007611-199810000-00006\nGoetzel, 1998, The relationship between modifiable health risks and health care expenditures: an analysis of the multi-employer HERO risk and cost database, J Occup Environ Med, 40, 843, 10.1097\u002F00043764-199810000-00003\nWasserman, 2000, Gender-specific effects of modifiable health risk factors on coronary heart disease and related expenditures, J Occup Environ Med, 42, 1060, 10.1097\u002F00043764-200011000-00005\nWadhwa, 1993, The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation, Am J Obstet Gynecol, 169, 858, 10.1016\u002F0002-9378(93)90016-C\nBrett, 1997, Employment, job strain, and preterm delivery among women in North Carolina, Am J Public Health, 87, 199, 10.2105\u002FAJPH.87.2.199\nHobel, 2003, Role of psychosocial and nutritional stress on poor pregnancy outcome, J Nutr, 133, 17909S, 10.1093\u002Fjn\u002F133.5.1709S\nLobel, 1994, Conceptualizations, measurement and effects of prenatal maternal stress on birth outcomes, J Behav Med, 17, 225, 10.1007\u002FBF01857952\nRondo, 2003, Maternal psychological stress and distress as predictors of low birth weight, prematurity and intrauterine growth retardation, Eur J Clin Nutr, 57, 266, 10.1038\u002Fsj.ejcn.1601526\nWadhwa, 2004, Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation, Am J Obstet Gynecol, 191, 1063, 10.1016\u002Fj.ajog.2004.06.070\nHedegaard, 1996, Do stressful life events affect duration of gestation and risk of preterm delivery?, Epidemiology, 7, 339, 10.1097\u002F00001648-199607000-00001\nSandman, 1997, Maternal stress, HPA activity, and fetal\u002Finfant outcome, Ann N Y Acad Sci, 814, 266, 10.1111\u002Fj.1749-6632.1997.tb46162.x\nHobel, 1999, Maternal plasma corticotrophin-releasing hormone associated with stress at 20 weeks gestation in pregnancies ending in preterm delivery, Am J Obstet Gynecol, 180, S257, 10.1016\u002FS0002-9378(99)70712-X\nSanchez, 1996, Autoradiographic evidence of mu opioid receptor down-regulation after prenatal stress in offspring rat brain, Dev Brain Res, 94, 14, 10.1016\u002F0165-3806(96)00032-6\nSanchez, 2000, Autoradiographic evidence of delta opioid receptor down-regulation after prenatal stress in offspring rat brain, Pharmacology, 60, 13, 10.1159\u002F000028341\n\u003Chttp:\u002F\u002Fwww.cdc.gov\u002Fnchs\u002Fproducts\u002Fpubs\u002Fpubd\u002Fhestats\u002Foverwght99.htm>\nFinkelstein, 2004, State-level estimates of annual medical expenditures attributable to obesity, Obes Res, 12, 18, 10.1038\u002Foby.2004.4\nGuo, 1999, Tracking of body mass index in children in relation to overweight in adulthood, Am J Clin Nutr, 70, 145S, 10.1093\u002Fajcn\u002F70.1.145s\nToobert, 2002, Enhancing support for health behavior change among women at risk for heart disease: the Mediterranean Lifestyle Trial, Health Educ Res, 17, 574, 10.1093\u002Fher\u002F17.5.574\nLaitinen, 2002, Stress-related eating and drinking behavior and body mass index and predictors of this behavior, Prev Med, 34, 29, 10.1006\u002Fpmed.2001.0948\nBrehm, 2003, Psychosocial outcomes of a pilot multidisciplinary program for weight management, Am J Health Behav, 27, 348, 10.5993\u002FAJHB.27.4.6\nBradshaw, 2004, A randomised trial of three non-dieting programs for overweight women, Asia Pac J Clin Nutr, 13, S43\nWestenhoefer, 2004, Behavioural correlates of successful weight reduction over 3 y. Results from the lean habits study, Int J Obes Relat Metab Disord, 28, 334, 10.1038\u002Fsj.ijo.0802530\nRosmond, 2000, The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke, J Int Med, 247, 188, 10.1046\u002Fj.1365-2796.2000.00603.x\nTulloch-Reid, 2003, Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity, Diabetes Care, 26, 2556, 10.2337\u002Fdiacare.26.9.2556\nMcEwen, 2002, Protective and damaging effects of stress mediators: the good and the bad sides of the response to stress, Metabolism, 51, 2, 10.1053\u002Fmeta.2002.33183\nRosmond, 2000, Occupational status, cortisol secretory pattern, and visceral obesity in middle aged men, Obes Res, 8, 445, 10.1038\u002Foby.2000.55\nDiabetes prevention research group, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056\u002FNEJMoa012512\nSurwit, 2002, Stress management improves long-term glycemic control in type 2 diabetes, Diabetes Care, 25, 30, 10.2337\u002Fdiacare.25.1.30\nIsmail, 2004, Systematic review and meta-analysis of randomized controlled trials of psychological interventions to improve glycemic control in patients with type 2 diabetes, Lancet, 363, 1589, 10.1016\u002FS0140-6736(04)16202-8\nKarlsen, 2004, Effects of a group-based counselling programme on diabetes-related stress, coping, psychological well-being and metabolic control in adults with type 1 or type 2 diabetes, Patient Educ Couns, 53, 299, 10.1016\u002Fj.pec.2003.10.008\nBlumenthal, 2002, Biobehavioral approaches to the treatment of essential hypertension, J Consult Clin Psychol, 70, 569, 10.1037\u002F0022-006X.70.3.569\nLinden, 2001, Individualized stress management for primary hypertension, Arch Int Med, 161, 1071, 10.1001\u002Farchinte.161.8.1071\nSpence, 1999, Lifestyle modifications to prevent and control hypertension. 7. Recommendations on stress management, Can Med Assoc J, 160, S46\nPatel, 1975, Randomized controlled trial of yoga and bio-feedback in management of hypertension, Lancet, 306, 93, 10.1016\u002FS0140-6736(75)90002-1\nPatel, 1975, 12-month follow-up of yoga and bio-feedback in the management of hypertension, Lancet, 305, 62, 10.1016\u002FS0140-6736(75)91070-3\nPatel, 1988, Can general practitioners use training in relaxation and management of stress to reduce mild hypertension?, Br Med J Clin Res Ed, 296, 21, 10.1136\u002Fbmj.296.6614.21\nPatel, 1985, Trial of relaxation in reducing coronary risk: four year follow-up, Br Med J Clin Res Ed, 290, 1103, 10.1136\u002Fbmj.290.6475.1103\nPatel, 1987, Stress management, blood pressure and quality of life, J Hypertens, 5, S21\nViskoper, 2003, Nonpharmacologic treatment of resistant hypertensives by device-guided slow breathing exercises, Am J Hypertens, 16, 484, 10.1016\u002FS0895-7061(03)00571-5\nNovak, 1994, Altered cardiorespiratory transfer in hypertension, Hypertension, 23, 104, 10.1161\u002F01.HYP.23.1.104\nPitzalis, 1998, Effect of respiratory rate on the relationships between RR interval and systolic blood pressure fluctuations: a frequency-dependent phenomenon, Cardiovasc Res, 38, 332, 10.1016\u002FS0008-6363(98)00029-7\nDaly, 1995, Aspects of the integration of the respiratory and cardiovascular system, 15\nSapolsky, 2004, Is impaired neurogenesis relevant to the affective symptoms of depression?, Biol Psychiatry, 56, 137, 10.1016\u002Fj.biopsych.2004.04.012\nLiu, 1997, Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress, Science, 277, 1659, 10.1126\u002Fscience.277.5332.1659\nShannon, 2001, Changes in general health and musculoskeletal outcomes in the workforce of a hospital undergoing rapid change: a longitudinal study, J Occup Health Psychol, 6, 3, 10.1037\u002F1076-8998.6.1.3\nMarmot, 1984, Inequalities in death-specific explanations of a general pattern?, Lancet, 1, 1003, 10.1016\u002FS0140-6736(84)92337-7\nMarmot, 1987, Social\u002Feconomic status and disease, Annu Rev Public Health, 8, 111, 10.1146\u002Fannurev.pu.08.050187.000551\nWasserman, 2000, Gender-specific effects of modifiable health risk factors on coronary heart disease and related expenditures. HERO Research Committee. Health Enhancement Research Organization, J Occup Environ Med, 42, 1060, 10.1097\u002F00043764-200011000-00005\nGoetzel, 1998, The relationship between modifiable health risks and health care expenditures: an analysis of the multi-employer HERO risk and cost database, J Occup Environ Med, 40, 843, 10.1097\u002F00043764-199810000-00003\nGoetzel, 2002, The business case for quality mental health services: why employers should care about the mental health and well-being of their employees, J Occup Environ Med, 44, 320, 10.1097\u002F00043764-200204000-00012\nMusich, 2000, Effectiveness of health promotion programs in moderating medical costs in the USA, Health Promot Int, 15, 5, 10.1093\u002Fheapro\u002F15.1.5\nKivimaki, 2002, Work stress and risk of cardiovascular mortality: prospective cohort study of industrial employees, BMJ, 325, 857, 10.1136\u002Fbmj.325.7369.857\nZavala, 2002, Decision latitude and workload demand: implications for full and partial absenteeism, J Public Health Policy, 23, 344, 10.2307\u002F3343229\nKuper, 2002, When reciprocity fails: effort-reward imbalance in relation to coronary heart disease and health functioning within the Whitehall II study, Occup Environ Med, 59, 777, 10.1136\u002Foem.59.11.777\nAvery, 2001, Bright light therapy of subsyndromal seasonal affective disorder in the workplace: morning vs afternoon exposure, Acta Psychiatry Scand, 103, 267, 10.1034\u002Fj.1600-0447.2001.00078.x\nMiilunpalo, 1997, Self-rated health status as a health measure: the predictive value of self-reported health status on the use of physician services and on mortality in the working-age population, J Clin Epidemiol, 50, 517, 10.1016\u002FS0895-4356(97)00045-0\nAl-Windi, 2002, The influence of perceived health and reported symptoms on health care utilization: a population based study, J Clin Epidemiol, 55, 60, 10.1016\u002FS0895-4356(01)00423-1\nHouse, 1988, Social relationships and health, Science, 241, 540, 10.1126\u002Fscience.3399889\nBerkman, 1995, The role of social relations in health promotion, Psychosom Med, 57, 245, 10.1097\u002F00006842-199505000-00006\nSeeman, 1996, Social ties and health: the benefits of social integration, Ann Epidemiol, 6, 442, 10.1016\u002FS1047-2797(96)00095-6\nHelgeson, 1998, Social ties and cancer, 99\nVroman, 2001, Non-work factors associated with musculoskeletal upper extremity disorders in women: beyond the work environment, Work, 17, 3\nKario, 2002, The influence of work- and home-related stress on the levels and diurnal variation of ambulatory blood pressure and neurohormonal factors in employed women, Hypertens Res, 25, 499, 10.1291\u002Fhypres.25.499\nStalnikowicz, 2002, Acute psychosocial stress and cardiovascular events, Am J Emerg Med, 20, 488, 10.1053\u002Fajem.2002.34788\nAlfredsson, 2002, Job strain and major risk factors for coronary heart disease among employed males and females in a Swedish study on work, lipids and fibrinogen, Scand J Work Environ Health, 28, 238, 10.5271\u002Fsjweh.671\nNiaura, 2002, Hostility, the metabolic syndrome, and incident coronary heart disease, Health Psychol, 21, 588, 10.1037\u002F0278-6133.21.6.588\nSmith, 2002, Psychosocial influences on the development and course of coronary heart disease: current status and implications for research and practice, J Consult Clin Psychol, 70, 548, 10.1037\u002F0022-006X.70.3.548\n2001",{"EN":1066},"Stressor-induced alteration of health across the life span: There's more to it than immunology",{"VOID":1068},"10.1016\u002Fj.cair.2005.03.001","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1529104905000310",[1071],{"id":1072,"sortIndex":36,"researcher":26,"roles":1073,"affiliations":1074,"properties":1083},"7b5f7e23-94f4-44ff-b4ee-bc3b69597fb6",[753],[1075],{"id":26,"sortIndex":36,"affiliation":1076,"properties":26},{"id":1077,"createTime":1078,"updateTime":1078,"relativeEntities":1079,"slug":26,"properties":1080,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"f7a0ffd6-efbe-40fa-92d6-f053f3367b4a","2024-01-27T17:06:11.676+00:00",[],{"title":1081},{"VI":1082},"UPMC Healthy Lifestyle Program, 200 Lothrop St, Pittsburgh, PA 15213-2582, USA",{"title":1084},{"VI":1085},"Bruce S. Rabin",{"url":1069,"publisher":1087,"properties":1101},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":1088,"slug":663,"properties":1089,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1092,"manageAffiliations":1093,"indexDatabases":1094,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1090,"title":1091},{"VOID":666},{"EN":668},[],[],[1095],{"id":673,"indexDatabase":1096,"url":686,"indexYears":687,"academicFieldIds":26,"indexDatabaseRanking":688},{"id":675,"createTime":676,"updateTime":677,"relativeEntities":1097,"label":1098,"description":1099,"key":683,"publicationTags":1100,"standard":26},[],{"EN":680,"VI":680},{"EN":680,"VI":682},[685],{"volume":1102,"pages":1103},{"VOID":876},{"VOID":1104},"207-224","2005-05-01",{"id":1107,"createTime":1108,"updateTime":1109,"relativeEntities":1110,"slug":1111,"properties":1112,"entityType":704,"verifyStatus":25,"verifyTime":1109,"verifyNote":747,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1119,"fullTextUrl":26,"authors":1120,"publicationType":708,"publisherRelationship":1186,"citationCount":26,"citationInfo":26,"publishDate":1205,"publishYear":994,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":733},"98323c41-1d36-4fee-a902-0ee545ee494c","2024-01-08T21:47:16.633+00:00","2025-02-06T17:08:09.204+00:00",[],"Natural-killer-cell-function-in-chronic-fatigue-syndrome",{"references":1113,"title":1115,"doi":1117},{"VOID":1114},"Holmes, 1988, Chronic fatigue syndrome, Ann Intern Med, 108, 387, 10.7326\u002F0003-4819-108-3-387\nFukuda, 1994, International CFS Study Group. The chronic fatigue syndrome, Ann Intern Med, 121, 953, 10.7326\u002F0003-4819-121-12-199412150-00009\nKlimas, 1992, Chronic fatigue syndrome and psychoneuroimmunology, 121\nChester, 1994, Concurrent sick building syndrome and chronic fatigue syndrome, Clin Infect Dis, 18, S43, 10.1093\u002Fclinids\u002F18.Supplement_1.S43\nAblashi, 1995, Viruses and chronic fatigue syndrome, J Chronic Fatigue Syndrome, 1, 3, 10.1300\u002FJ092v01n02_02\nGlaser, 1998, Stress-associated immune modulation, Am J Med, 105, 35S, 10.1016\u002FS0002-9343(98)00160-0\nWhiteside, 1998, Natural killer cells and natural killer cell activity in chronic fatigue syndrome, Am J Med, 105, 27S, 10.1016\u002FS0002-9343(98)00155-7\nPatarca, 2001, Cytokine and other immunologic markers in chronic fatigue syndrome and their relationship to neuropsychological factors, Applied Neuropsychiatry, 8, 51, 10.1207\u002FS15324826AN0801_7\nPatarca, 2000, Immunology of chronic fatigue syndrome, J Chronic Fatigue Syndrome, 6, 69, 10.1300\u002FJ092v06n03_06\nLloyd, 1990, Prevalence of chronic fatigue syndrome in an Australian population, Med J Aust, 153, 522, 10.5694\u002Fj.1326-5377.1990.tb126191.x\nSharpe, 1991, A report on chronic fatigue syndrome, J Royal Soc Med, 84, 118, 10.1177\u002F014107689108400123\nJason, 1997, A screening scale for chronic fatigue syndrome, J Chronic Fatigue Syndrome, 3, 39, 10.1300\u002FJ092v03n01_04\nJason, 2000, Defining chronic fatigue syndrome, J Chronic Fatigue Syndr., 7, 17, 10.1300\u002FJ092v07n03_03\nKibler, 1985, Immune function in chronic active Epstein-Barr virus infection, J Clin Immunol., 5, 46, 10.1007\u002FBF00915168\nCaligiuri, 1987, Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome, J Immunol, 139, 3306, 10.4049\u002Fjimmunol.139.10.3306\nAoki, 1991, Low NK syndrome and its relationship to chronic fatigue syndrome, Clin Immunol Immunopath, 69, 253, 10.1006\u002Fclin.1993.1178\nAoki, 1987, Low natural syndrome, Nat Immun Cell Growth Regul., 6, 116\nAoki, 1985, A novel immunodeficiency, Jpn J Med, 3212, 14\nHerberman, 1975, Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity, Int J Cancer, 16, 216, 10.1002\u002Fijc.2910160204\nKlimas, 1990, Immunologic abnormalities in chronic fatigue syndrome, J Clin Microbiol, 28, 1403, 10.1128\u002FJCM.28.6.1403-1410.1990\nPatarca, 1995, Cytolytic cell functions, 296\nTirelli, 1993, Clinical and immunological study of 205 patients with chronic fatigue syndrome, Arch Intern Med, 153, 116, 10.1001\u002Farchinte.1993.00410010136014\nBarker, 1994, Immunologic abnormalities associated with chronic fatigue syndrome, Clin Infect Dis, 18, S136, 10.1093\u002Fclinids\u002F18.Supplement_1.S136\nMasuda, 1994, Psychobehavioral and immunological characteristics of adult people with chronic fatigue and patients with chronic fatigue syndrome, Psychosom Med, 56, 516, 10.1097\u002F00006842-199411000-00006\nOjo-Amaise, 1994, Decreased natural killer cell activity is associated with severity of chronic fatigue immune deficiency syndrome, Clin Infect Dis, 18, S157, 10.1093\u002Fclinids\u002F18.Supplement_1.S157\nLevine, 1998, Dysfunction of natural killer activity in a family with chronic fatigue syndrome, Clin Immunol Immunopath, 88, 96, 10.1006\u002Fclin.1998.4554\nSee, 1997, In vitro effects of echinacea and ginsing on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients, Immunopharm, 35, 229, 10.1016\u002FS0162-3109(96)00125-7\nGold, 1990, Chronic fatigue. A prospective clinical and virologic study, JAMA, 264, 48, 10.1001\u002Fjama.1990.03450010052029\nRasmussen, 1994, Chronic fatigue syndrome—a controlled cross sectional study, J Rheumatol, 21, 1527\nMawle, 1997, Immune responses associated with chronic fatigue syndrome, J Infect Dis, 175, 136, 10.1093\u002Finfdis\u002F175.1.136\nReeves, 2000, Human herpesviruses 6 and 7 in chronic fatigue syndrome, Clin Infect Dis, 31, 48, 10.1086\u002F313908\nBuchwald, 1992, A chronic illness characterized by fatigue, neurologic and immunologic disorders and active herpesvirus type 6 infection, Ann Intern Med, 116, 103, 10.7326\u002F0003-4819-116-2-103\nAblashi, 2000, Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients, J Clin Virol, 16, 179, 10.1016\u002FS1386-6532(99)00079-7\nOgawa, 1998, Decreased nitric oxide-mediated natural killer cell activation in chronic fatigue syndrome, European J Clin Invest, 28, 937, 10.1046\u002Fj.1365-2362.1998.00373.x\nJason, 1999, A community based study of chronic fatigue syndrome, Arch Intern Med, 159, 2129, 10.1001\u002Farchinte.159.18.2129",{"EN":1116},"Natural killer cell function in chronic fatigue syndrome",{"VOID":1118},"10.1016\u002Fs1529-1049(01)00047-2","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1529104901000472",[1121,1148,1167],{"id":1122,"sortIndex":115,"researcher":26,"roles":1123,"affiliations":1124,"properties":1145},"73eb4bc8-d1dc-4974-8066-f2dae1053a13",[753],[1125,1133],{"id":26,"sortIndex":36,"affiliation":1126,"properties":26},{"id":1127,"createTime":1128,"updateTime":1128,"relativeEntities":1129,"slug":26,"properties":1130,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"1e98b7c0-9f4a-4517-827e-d7f9bf6ffc85","2024-01-08T21:47:16.677+00:00",[],{"title":1131},{"VI":1132},"E. M. Papper Laboratory of Clinical Immunology, University of Miami School of Medicine, Miami, FL 33101, USA",{"id":1134,"sortIndex":115,"affiliation":1135,"properties":1144},"a3272ec2-336f-40e8-890e-4658068aa879",{"id":1136,"createTime":1137,"updateTime":1138,"relativeEntities":1139,"slug":1140,"properties":1141,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"0062893a-c507-4627-a2f5-80df42571b40","2024-01-08T21:47:16.665+00:00","2025-06-11T13:53:10.506+00:00",[],"Center-for-Behavioral-Medicine-Research-Miami-Veterans-Administration-Medical-Center-P-O-Box-016960-Miami-FL-33101-USA",{"title":1142},{"VI":1143},"Center for Behavioral Medicine Research, Miami Veterans Administration Medical Center P.O. Box 016960 Miami, FL 33101, USA",{},{"title":1146},{"VI":1147},"Kevin J Maher",{"id":1149,"sortIndex":114,"researcher":26,"roles":1150,"affiliations":1151,"properties":1164},"e88723cb-fd56-46a8-a650-a44ca0115710",[753],[1152,1159],{"id":1153,"sortIndex":115,"affiliation":1154,"properties":1158},"aeb790d9-12a4-4592-9656-accda0f5c320",{"id":1136,"createTime":1137,"updateTime":1138,"relativeEntities":1155,"slug":1140,"properties":1156,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1157},{"VI":1143},{},{"id":26,"sortIndex":36,"affiliation":1160,"properties":26},{"id":1127,"createTime":1128,"updateTime":1128,"relativeEntities":1161,"slug":26,"properties":1162,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1163},{"VI":1132},{"title":1165},{"VI":1166},"Nancy G Klimas",{"id":1168,"sortIndex":36,"researcher":26,"roles":1169,"affiliations":1170,"properties":1183},"b1c0fa59-cf50-4df5-848e-524e8bfbcc18",[753],[1171,1178],{"id":1172,"sortIndex":115,"affiliation":1173,"properties":1177},"83d873bb-eb5d-4113-ab49-4e1a4d5adbc9",{"id":1136,"createTime":1137,"updateTime":1138,"relativeEntities":1174,"slug":1140,"properties":1175,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1176},{"VI":1143},{},{"id":26,"sortIndex":36,"affiliation":1179,"properties":26},{"id":1127,"createTime":1128,"updateTime":1128,"relativeEntities":1180,"slug":26,"properties":1181,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1182},{"VI":1132},{"title":1184},{"VI":1185},"Mary Ann Fletcher",{"url":1119,"publisher":1187,"properties":1201},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":1188,"slug":663,"properties":1189,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1192,"manageAffiliations":1193,"indexDatabases":1194,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1190,"title":1191},{"VOID":666},{"EN":668},[],[],[1195],{"id":673,"indexDatabase":1196,"url":686,"indexYears":687,"academicFieldIds":26,"indexDatabaseRanking":688},{"id":675,"createTime":676,"updateTime":677,"relativeEntities":1197,"label":1198,"description":1199,"key":683,"publicationTags":1200,"standard":26},[],{"EN":680,"VI":680},{"EN":680,"VI":682},[685],{"volume":1202,"pages":1203},{"VOID":914},{"VOID":1204},"129-139","2002-04-01",{"id":1207,"createTime":1208,"updateTime":1209,"relativeEntities":1210,"slug":1211,"properties":1212,"entityType":704,"verifyStatus":25,"verifyTime":1217,"verifyNote":747,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1218,"fullTextUrl":26,"authors":1219,"publicationType":708,"publisherRelationship":1259,"citationCount":26,"citationInfo":26,"publishDate":1279,"publishYear":994,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":733},"46a17b54-dfa2-41de-9c5f-2106e63ddde3","2023-12-26T14:59:46.571+00:00","2025-01-16T11:33:42.405+00:00",[],"Detection-of-IGA-and-IGG-anti-human-red-blood-cell-tissue-transglutaminase-and-diagnosis-of-celiac-disease",{"title":1213,"doi":1215},{"EN":1214},"Detection of IGA and IGG anti-human red blood cell tissue transglutaminase and diagnosis of celiac disease",{"VOID":1216},"10.1016\u002Fs1529-1049(02)00078-8","2025-01-16T11:33:42.404+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1529104902000788",[1220,1235,1247],{"id":1221,"sortIndex":36,"researcher":26,"roles":1222,"affiliations":1223,"properties":1232},"81579629-8baf-4a11-b091-baaa2b7751ce",[753],[1224],{"id":26,"sortIndex":36,"affiliation":1225,"properties":26},{"id":1226,"createTime":1227,"updateTime":1227,"relativeEntities":1228,"slug":26,"properties":1229,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"9108f453-8e90-4c0f-b612-8db2f9174fc4","2023-12-26T14:59:46.601+00:00",[],{"title":1230},{"VI":1231},"INOVA Diagnostics, San Diego, CA, USA",{"title":1233},{"VI":1234},"S. Lewis",{"id":1236,"sortIndex":115,"researcher":26,"roles":1237,"affiliations":1238,"properties":1244},"54150a9f-75c0-44ad-bb84-a584c85bf442",[753],[1239],{"id":26,"sortIndex":36,"affiliation":1240,"properties":26},{"id":1226,"createTime":1227,"updateTime":1227,"relativeEntities":1241,"slug":26,"properties":1242,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1243},{"VI":1231},{"title":1245},{"VI":1246},"V. Nelson",{"id":1248,"sortIndex":114,"researcher":26,"roles":1249,"affiliations":1250,"properties":1256},"81726af4-1c4d-4a24-bf7b-3540d45ee5d0",[753],[1251],{"id":26,"sortIndex":36,"affiliation":1252,"properties":26},{"id":1226,"createTime":1227,"updateTime":1227,"relativeEntities":1253,"slug":26,"properties":1254,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1255},{"VI":1231},{"title":1257},{"VI":1258},"W. Binder",{"url":1218,"publisher":1260,"properties":1274},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":1261,"slug":663,"properties":1262,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1265,"manageAffiliations":1266,"indexDatabases":1267,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1263,"title":1264},{"VOID":666},{"EN":668},[],[],[1268],{"id":673,"indexDatabase":1269,"url":686,"indexYears":687,"academicFieldIds":26,"indexDatabaseRanking":688},{"id":675,"createTime":676,"updateTime":677,"relativeEntities":1270,"label":1271,"description":1272,"key":683,"publicationTags":1273,"standard":26},[],{"EN":680,"VI":680},{"EN":680,"VI":682},[685],{"volume":1275,"pages":1277},{"VOID":1276},"3",{"VOID":1278},"14","2002-11-01",{"id":1281,"createTime":1282,"updateTime":1283,"relativeEntities":1284,"slug":1285,"properties":1286,"entityType":704,"verifyStatus":25,"verifyTime":1283,"verifyNote":747,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1291,"fullTextUrl":26,"authors":1292,"publicationType":708,"publisherRelationship":1332,"citationCount":26,"citationInfo":26,"publishDate":1279,"publishYear":994,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":733},"a2bfb422-5838-49f8-89de-ba5e65a24dad","2023-12-23T05:25:38.701+00:00","2024-12-16T17:31:21.390+00:00",[],"Improvements-in-the-clinical-sensitivity-of-ANA-ELISA-testing",{"title":1287,"doi":1289},{"EN":1288},"Improvements in the clinical sensitivity of ANA ELISA testing",{"VOID":1290},"10.1016\u002Fs1529-1049(02)00071-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1529104902000715",[1293,1308,1320],{"id":1294,"sortIndex":114,"researcher":26,"roles":1295,"affiliations":1296,"properties":1305},"637eec97-56b7-4b0e-a3bf-ba48048f249c",[753],[1297],{"id":26,"sortIndex":36,"affiliation":1298,"properties":26},{"id":1299,"createTime":1300,"updateTime":1300,"relativeEntities":1301,"slug":26,"properties":1302,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b88bf830-d608-4272-a556-b8303050b21d","2023-12-23T05:25:38.721+00:00",[],{"title":1303},{"VI":1304},"INOVA Diagnostics, Inc., San Diego, CA USA",{"title":1306},{"VI":1307},"R.W. Burlingame",{"id":1309,"sortIndex":36,"researcher":26,"roles":1310,"affiliations":1311,"properties":1317},"d4633107-20e9-43fe-aae7-16aa76bf9bdf",[753],[1312],{"id":26,"sortIndex":36,"affiliation":1313,"properties":26},{"id":1299,"createTime":1300,"updateTime":1300,"relativeEntities":1314,"slug":26,"properties":1315,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1316},{"VI":1304},{"title":1318},{"VI":1319},"P. Martis",{"id":1321,"sortIndex":115,"researcher":26,"roles":1322,"affiliations":1323,"properties":1329},"47d3df11-4391-49ab-b0c5-64e8fd84c0db",[753],[1324],{"id":26,"sortIndex":36,"affiliation":1325,"properties":26},{"id":1299,"createTime":1300,"updateTime":1300,"relativeEntities":1326,"slug":26,"properties":1327,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1328},{"VI":1304},{"title":1330},{"VI":1331},"A.L. Piette",{"url":1291,"publisher":1333,"properties":1347},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":1334,"slug":663,"properties":1335,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1338,"manageAffiliations":1339,"indexDatabases":1340,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1336,"title":1337},{"VOID":666},{"EN":668},[],[],[1341],{"id":673,"indexDatabase":1342,"url":686,"indexYears":687,"academicFieldIds":26,"indexDatabaseRanking":688},{"id":675,"createTime":676,"updateTime":677,"relativeEntities":1343,"label":1344,"description":1345,"key":683,"publicationTags":1346,"standard":26},[],{"EN":680,"VI":680},{"EN":680,"VI":682},[685],{"volume":1348,"pages":1349},{"VOID":1276},{"VOID":1350},"9"]